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Medical treatments carry unique benefits and risks which patients must understand in 
order to decide which of their options is best for them.  Prior research has 
demonstrated that patients are ill-equipped to understand both medical terminology 
and the statistical information presented to them through standard decision aids.  
Patients are unable to use the information about treatments to make decisions and as a 
result make poor choices with regards to their healthcare.  The contributions of this 
work are 1) a multi-dimensional model for describing the content of decision aids; 2) 
TreatmentExplorer, a prototype interactive decision aid designed to communicate 
treatment risks and benefits through the use of visualization, animation, and guided 
narration; 3) an evaluation of TreatmentExplorer with four experts in health 
communication; 4) a preliminary usability evaluation comparing the performance of 
TreatmentExplorer against design alternatives, and 5) guidelines for interactive 
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Chapter 1: Introduction 
 
1.1 Problem Definition 
Medical patients are increasingly required to make difficult decisions about their 
treatment while under stress.  They must become knowledgeable about their possibly 
complex conditions and unfamiliar treatment options, sometimes in a short period of 
time.  Along with coming to an understanding of their condition, medical patients 
face treatments that carry unique benefits and risks.  Evidence-based medicine 
promotes the ideal that patients should be given data about their treatment options so 
that they can come to a logical decision based on treatments that have the greatest 
efficacy.   
Unfortunately, patients are often unable to use the information presented to 
them about treatments to make decisions and as a result make poor choices with 
regards to their healthcare.  Patients impose their own preferences on their medical 
care in terms of lifestyle-impacting side effects which they are willing to cope with as 
part of their treatment [1].  It has been reported that even with the data to reach a 
logical decision, patients often base their treatment decisions on their emotional 
reactions rather than rational decision-making [2] [3].  Patients face other obstacles to 
their rational decision making beyond their emotional state.  It is widely noted that 
patients are ill-equipped to understand both medical terminology and the statistical 
data presented to them in decision aids.  Quantitative information presented in tables 




have difficulties reading and understanding textual presentations of treatment 
information [4].  Interpretation of both numeric and textual information is a frequent 
hazard [5].   
The increasing availability of laptops, tablets, smart phones, and the 
widespread use of the internet makes the problems facing patients and their 
information needs more important than ever.  Patients are taking the initiative to learn 
more about their conditions from online sources [6].  This implies an increased 
expectation by patients to have access to relevant, reliable health information on 
demand.  Work is needed to understand how to best leverage the affordances of 
online technologies and personal computing devices such that patients can both 
access and use health information to make better health decisions.  Decision aids must 
be prepared that can support patients on demand as well as overcome patient skill 
deficiencies.  Thus, the design of a useful decision aid faces challenges of risk 
communication and health literacy as well as other challenges such as the placement 
of a decision aid within a medical workflow.  The following sections outline 
unanswered research questions from these three related fields which have driven the 
design of a prototype medical decision aid, TreatmentExplorer. 
Risk Communication 
Research investigating the communication of risk in healthcare has consistently 
demonstrated one great challenge: patients are generally poor with statistics, even 
when educated.  The study of risk communication within the medical domain strives 




to the average patient.  Much of this work examines the role of graphics and the 
features of graphics that increase patient knowledge.  Unanswered questions from the 
study of medical risk communication include [7] [8]: 
 Which graphical formats are patients able to accurately read? 
 How does the presentation of equivalent measures such as frequency or 
percentage affect patient understanding (i.e. 5 out of 10 patients vs. 50% of 
patients)? 
 Does the order of information produce a bias towards or against a treatment? 
 How does framing of risk (incremental vs. absolute, gain vs. loss) affect its 
interpretation? 
Health Literacy 
Patients do not have medical expertise and cannot easily understand medical 
terminology, treatments, or their options.  Basic terminology and standard medical 
procedures are daunting onsets of information overload, especially when a patient is 
also emotionally burdened with a recent diagnosis of a serious medical condition.  
Before a patient can begin to understand the evidence supporting treatment options, 
they must first be able to understand what information they have and be comfortable 
navigating through decision aids and other informative materials.  Health literacy is a 
problem for otherwise literate patients and compounds the obstacles faced by non-
literate patients.  Supporting the health literacy of patients is critical as low health 




including increased hospitalization, higher mortality rates, and difficulties with 
disease management [9].  Design concerns for low-literacy patients include [4] [8]: 
 What literacy level should be targeted by a decision aid? 
 How can the needs of low-literacy patients be met without compromising data 
presentation? 
 What features of a decision aid are most adversely affected by low literacy or 
numeracy? 
Medical Decision Aids 
Medical decision aids have served their purpose if they convey one data point and 
leave the burden of assimilating and understanding to the patient.  Despite this 
additional cognitive burden, decision aids are consistently shown to reduce patient 
anxiety, reduce passivity, promote realistic perceptions of treatment benefits and 
harm, reduce negative emotions, and increase patient knowledge about risks and 
treatment options [10] [3] [11] [12].  Other work has shown that more guidance from 
trained medical professionals such as physicians or nurse practitioners improves 
patient understanding of risks as well as patient satisfaction with treatment options 
[10] [13] [12] [14].  This suggests there is room for improvement in decision aids 
with respect to their use as communication tools for patients and physicians.  
Information needs of patients and physicians need to be better understood as well as 
where communication interventions belong within the healthcare process.  Open 




 How can patient-centered communication at the physician or clinic level 
improve patient understanding of their treatment options? 
 Where in the workflow of healthcare is the most appropriate place for 
evidence-based treatment information? 
 What are the information needs of a patient and how do they differ from the 
medical professionals supporting them in their care? 
1.2 Design Goals 
An information visualization approach to the preceding challenges would begin with 
the following design goals: 
Support Multiple Treatment Options 
Patients often learn about their treatment options in isolation.  The burden of 
consolidating the information about each treatment falls to them.  Varying 
information sources provide varying types of information.  A more ideal solution 
would support the comparison of multiple treatment options in the same space by 
making the same information available about all possible treatment options. 
Go Beyond Treatment Success Rate 
Included in the most basic information patients typically receive about a treatment 
option is its chance of succeeding.  While this is important information, it does not 




treatment option would entail.  It is desirable for patients to be able to compare 
treatment side effects, costs, and other lifestyle factors for their treatment options. 
Capture Changes Over the Course of Treatment 
As a patient follows a care plan, their circumstances may change.  Some treatment 
options may have a cumulative effect on their condition (such as regular exercise on 
cardiovascular health).  Other treatments may offer immediate benefit but have 
diminishing returns over the course of a lifetime.  This information needs to be 
available to patients so they can anticipate how they may be impacted over the entire 
length of their care but is often missing from most healthcare information patients 
encounter. 
Leverage Real Outcomes from Real Patients 
Apart from scientific evidence and the results of clinical trials, the testimonials and 
support of other patients is an important source of information for some patients.  In 
fact, entire communities have arisen to provide just this type information [16].  
However, this also results in an additional burden of finding credible community 
resources.  Patients can benefit from knowledge of the treatment outcomes of real 
patients similar to themselves, but need a way of accessing credible information. 
1.3 Contributions 
The first contribution of this work is an analysis of the design space of medical 




based on a literature review, yields a multi-dimensional model which can be used to 
assess decision aids relating to a wide variety of conditions and demonstrates the 
information gaps patients must overcome when reconciling the information they 
gather from multiple sources.  It serves as a starting point to investigate questions 
about the impact of decision aid content on risk communication and the information 
content of medical decision aids. 
 
Figure 1.  The TreatmentExplorer prototype for medical risk communication and treatment 
option exploration. 
The second contribution of this work is a prototype a medical decision aid, 
TreatmentExplorer, which has been designed to address the information gaps 
identified through analysis using the dimensional model (see figures 1 and 2).  
TreatmentExplorer follows the best practices which have been put forth by related 
research and builds on that research with advanced features such as: 




 The representation of likely treatment outcomes for multiple points of time 
 The inclusion of multiple data points for each treatment 
 Personalization to patient-specific conditions 
 Guided narration of treatment highlights with animation 
 
Figure 2. Visualization portion of the TreatmentExplorer which shows the overall success of a 





TreatmentExplorer also provides a platform through which the preceding research 
questions from risk communication, health literacy, and medical decision aids may be 
answered experimentally with case studies and controlled experiments. 
As part of the design of TreatmentExplorer, experts in health and risk 
communication have evaluated early versions of the prototype and provided feedback 
on its features and ease of use.  This co-design process forms the third contribution of 
this work and resulted in additional best-practice recommendations for future decision 
aids. 
The fourth contribution of this work is the evaluation of TreatmentExplorer with a 
preliminary user evaluation.  This evaluation compares the knowledge gain 
participants experience when using TreatmentExplorer with the performance of 
participants using a baseline analog decision aid. 
Finally, the fifth contribution of this work is a set of guidelines for the use of text, 
graphics, animation, and guided narration derived from the results of the 










Chapter 2: Related Work 
 
 
TreatmentExplorer builds from the research of several fields including theoretical 
concepts of sense-making and thought visualization and empirically tested lessons 
from risk communication, health literacy, and decision aids.  It also draws from 
research in the domains of information visualization and storytelling. 
2.1 Sensemaking and Thought Visualization 
Dervin’s Sense-making theory describes the process by which individuals organize 
information in their attempt to reach an understanding (figure 3).  Emphasis is placed 
on sense making and unmaking as an active “verbing” process with knowledge 
considered to be the sense made of information at a particular point in time-space by 
someone [17].  In the process of sense making and unmaking, individuals “bridge the 
gap” between their current knowledge and new information based on their history and 
experience resulting in new knowledge as well as functions and dysfunctions [17].  
TreatmentExplorer responds to the call to support patient learning as an active 
process by providing a consistent representation of treatment options and probable 
patient outcomes.  Patient-users are able to explore treatments and leverage an 
organized presentation to help them make sense of the otherwise overwhelming 
amount of information.  This particularly addresses a tenet of sense-making theory 
which claims that interfaces designed dialogically with contributions anchored in 





Figure 3.  Dervin's Sense-Making Metaphor [18, p. 238] . 
Consistencies in visual communications provide insight into how people think 
and should be used to guide design [19].  Tversky discusses research supporting the 
use of spatial actions creating meaningful patterns such as groups and hierarchies 
[19].  Other uses of space indicate that vertical dimensions are preferred for graphics 
with values that can be evaluated such as sums with larger/higher values to higher 
spatial positions.  The horizontal dimension is preferred for neutral concepts such as 
time [19].  Bars in diagrams are frequently interpreted as containers which separate 
their contents from everything else and nested bars or frames can be used to indicate 
hierarchy among contents [19].  TreatmentExplorer builds on research into effective 
visual communication.  Patient groups and their size are represented along a vertical 
dimension as recommended while time is expressed along the horizontal axis in the 
TreatmentExplorer visualization.  Glyphs are avoided in favor of simple visual 




explanatory text supports patient learning and creates shared mappings as patients 
make use of TreatmentExplorer. 
2.2 Risk Communication 
Research efforts in risk communication seek to understand the most effective 
mechanisms for communicating probabilities of uncertain and possibly hazardous 
events to non-experts.  When applied to healthcare, the risks are often risks of 
disease, side effects, complications, and possibly death.  Information about these risks 
typically is provided by medical professionals attempting to guide non-expert patients 
through treatment decisions. 
 Bunge, Muhlhauser, and Steckelberg surveyed risk communication literature 
for quality criteria in an effort to compile the evidence for the supported criteria [20].  
They found that criteria established for the presentation of numerical data, verbal 
presentation of risks, diagrams, graphics, and charts were based on evidence.  
However, the content, loss-/gain-framing, and patient oriented outcome measures 
were based on ethical guidelines.  Little research support was available for backing 
criteria on the quality of evidence, pictures or drawings, patient narratives, cultural 
aspects, layout, language, and development process.  In this work, the focus is on 
making use of such established risk communication guidelines for presenting 
treatment options in a graphical way. 
 Levy et al. surveyed cancer risk calculators found on the internet to review 
their content and consistency [21].  Their results show that most risk calculators did 




the factors it used to assess cancer risk.  They warn that the potential to misinterpret 
cancer risk by using such sites puts patients at risk of making inappropriate medical 
decisions.  In a similar study, Waters et al. found that risk communication formats 
varied between websites with few health care industry affiliated sites providing 
comparative risk information while the majority of government affiliated sites did so 
[6].  Use of formats to reduce bias and facilitate comprehension varied widely.  In this 
work, the ability to explore multiple treatments and understand the details of each is a 
priority.  Comparison of treatment efficacy is facilitated through both textual and 
graphical representations which remain consistent across all treatments.  Content is 
designed to be provided through medical records providing credibility. 
 In their commentary, Fagerlin, Zikmund-Fisher, and Ubel provide 10 specific 
recommendations for improving risk communication which include recommendations 
on use of language, text, graphics, order of information, use of comparison, and 
presentation of time [22].  They note that frequencies are preferred for providing 
information about absolute risks and/or highlighting changes between levels of risk 
(figure 4).  They also recommend repeatedly drawing attention to the time interval 
over which a risk occurs and the inclusion of graphs and summary tables.  In this 
work, frequencies are available and the visualization builds on elements of the 
recommended pictographs.  A summary of treatment highlights is always present with 





Figure 4. Example bar graph format from [23] [22] which provides survival rate information for 
multiple treatment options and highlights treatment differences using both frequencies and 
color. 
 Other work in risk communication suggests that even physicians need 
assistance with evidence-based risk communication.  Factors affecting a physician’s 
test-ordering tendencies have been shown to include their tolerance of uncertainty and 
both physicians and patients alike have shown difficulties understanding certain 
statistical measures such as numbers needed to treat [11].  Han et al. have also 
examined the topic of uncertainty in risk communication and formed a taxonomy of 
types of uncertainty within health care in the attempt to help clarify the problem of its 
expression [24].  Follow-up work endeavored to produce novel visualizations capable 
of representing randomness and its effect on uncertainty [25] (see figure 5).  The 
work on TreatmentExplorer does not yet address uncertainty.  Rather, it bases the 
data it presents on the information in Electronic Health Records (See Chapter 4).  
Thus, risks presented represent actual reports of medical incidents from patients.  




suggests are confusing to patients and physicians.  This avoidance of measures to 
focus on other critical statistics also follows one of the recommendations put forth by 
[22] which is to present only the most critical information, even at the expense of 
completeness. 
 
Figure 5.  Novel visualization from Han et al. [25] to depict uncertainty within risk estimates. 
2.3 Health Literacy 
Healthy literacy research focuses on producing health-related messages that non-
experts can understand and use in making informed treatment choices.  The goal is to 
be able to produce health materials that patients with deficient skills (as well as 
patients without such deficiencies) are able to access.  There is not the same emphasis 
on presenting a specific number to patients, rather summary information and relative 




confirming that numeracy, graphicacy, and health literacy are correlated [4].  
Particularly, numeracy predicts graphicacy even after factors such as education are 
controlled for [4].  Other work supports the idea that factors such as numeracy affect 
both gist and verbatim knowledge of treatments in patients and that such knowledge 
is associated with medically superior treatment choices [26]. 
 For comparing high-level information such as the quality of treatment-
supporting evidence or a summarized rating of a treatment’s success, work has shown 
that icons such as star ratings or symbols are preferred over other representations such 
as figure 6 [27] [20].  Other research suggests that the presence of graphics increases 
the believability of information [28].  Verbal expressions such as “low”, “medium”, 
and “high” have been shown lead to misunderstandings between physicians and 
patients and interfere with patient understanding [5].  This work builds on these finds 
by making use of graphics to represent the high-level properties of treatments.  Where 
text is used, simple, numeric expressions of important information are used instead of 





Figure 6.  Alternative provider rating visualization studied by Hildon, Allwood, and Black in 
[27]. 
 Other health literacy related research attends to basic human-computer 
interaction issues such as navigation through information.  Menu structures were the 
focus of Chaudry et al. and their studies of chronically-ill, low literacy patients [29] 
(figure 7).  Their recommendations for menu systems are to use large widgets and to 
include “home” and “back” navigation options to enable quicker navigation.  Linear 
menu systems with breadcrumb-like trails were preferred as well as starting every 
task from the same location.  TreatmentExplorer follows these recommendations 
through use of a large navigation widget where each treatment is represented as both 
a labeled button and as part of a bar graph.  All the guided narrations in 
TreatmentExplorer are started from this single navigation widget and begin with the 





Figure 7.  Example linear navigation and menu style studied in [29] for suitability for low-
literacy patients. 
2.4 Decision Aids 
Decision aids are often evaluated as part of larger clinic systems where the focus is on 
the feasibility of their deployment and their role in patient-physician communication.  
Studies have explored decision aids in the role of support for medical professionals 
[30], physician-patient communication [13] [3], and patient education [15] [10] [31] 
[14]. 
 Decision aids invoked in the role of physician-patient communication aid have 
shown a number of effects.  Studies have shown that emotions such as anxiety 
interfere with a patient’s ability to reason about their healthcare and that this impacts 




productive and efficient physician consultations [15].  Guidance on important 
questions and the ability to educate family members about conditions are noted as 
important benefits of decision aids [15].  Figure 8 shows an example of one such 
question answering system from [32].  Visual representations provide memory 
prompts which reduce the cognitive load of patients during decision-making [14].  
Study results suggest that patients who use decision aids are able to express more 
emotions, use more cognitive terms, and verbalize decision-relevant feelings [14].  
TreatmentExplorer has been designed to fill this role in the patient care process: by 
educating patients and providing cognitive support for remembering treatment details, 
patients using TreatmentExplorer should be able to communicate more effectively 
with their physicians and participate more in their healthcare decision making 
processes.   
 
Figure 8. Screen captures from a prototype decision aid for cardiac patients to facilitate question 
asking and answering with their physicians and care providers (from [32]). 
 Along with decreased decisional conflict and easier communication, decision 
aids are associated with increased patient knowledge with the greatest gains from 
patients reporting low baseline knowledge [10].  Incorrect responses to survey 
questions dropped dramatically after patients had access to decision aids in [10].  




now to educate themselves and use the information they find in making healthcare 
decisions.  Patient education is one of the intended uses of TreatmentExplorer.  
Credible information derived from aggregated patient outcomes is provided to 
patients so that they can familiarize themselves with their treatment options. 
 Medical professionals can also benefit from decision aids and support 
systems.  Lee and Bakken [30] report of work which provided nurse practitioners 
decision aids designed to support adherence to clinical practice guidelines for patients 
managing obesity. Their results indicate that such assisted professionals were better 
able to adhere to clinical guidelines resulting in improved care of patients.  Patient 
goals were also captured with greater regularity and included as part of consultations.  
This emphasis on patient-centered interventions has been shown to increase the 
effectiveness in the nursing process [30].  TreatmentExplorer does not address a 
specific condition; rather, it supports medical professionals by providing a platform to 
communicate treatment information in an unbiased manner.  This support included 
unbiased representations of clinical evidence backing treatments.  Medical 
professionals benefit from the completeness of information in TreatmentExplorer as 
well as being able to use it as a starting point for patient-centered care.  
2.5 Information Visualization and Storytelling 
Information visualization research has always sought to establish the best practices 
for presenting data in the most salient ways.  Information analysis typically requires 
interactive visualizations through which users are able to gain insight into their data.  




the viewer’s perception and cognition of the information conveyed.  Important 
information can be emphasized and lesser relevant details de-emphasized through 
visual techniques.  TreatmentExplorer draws from such visual communication 
principles that have been studied in information visualization research. 
Kosara and Mackinlay in [35] argue that with the design space of information 
visualization well defined, suitable techniques can be found to represent most 
datasets.  However, they also argue that best practices for communicating data are 
lacking.  Storytelling is thus an ordered sequence of visualization steps which can 
include text that roughly correspond to time or causality.  Several storytelling 
scenarios exist within visualization research including self-running presentations for 
large audiences, live presentations, and individual or small-group presentations.  
TreatmentExplorer follows the design mold of these individual presentation 
scenarios.  Requirements for such individual presentations include flexibility and user 
control greater than that afforded by simple slideshows [35].  TreatmentExplorer 
explicitly follows this recommendation by providing a user driven guided narration in 
which the user controls the pace of the narration and has multiple animation options 
for transitioning between treatments. 
 In [36], visualizations from online journals, blogs, and instructional videos are 
analyzed for their techniques of storytelling with data graphics.  Salient features 
which provided value to narratives included annotations, visual highlighting, and 
consistent visual platforms.  In addition, it was noted that the use of single- frame 
interactivity helped encourage users to explore visualizations and provided a tacit 




advantage of all this storytelling techniques by using a consistent frame for all 
narrations and annotating individual changes in the visualization as the narration 
progresses.  TreatmentExplorer also provides animated transitions which have been 
credited with making these changes clear to users [36]. 
 Automated systems are desirable when it comes to providing users with 
narratives to explain their data.  Hullman, Diakopoulos, and Adar report on work 
which aggregates and summarizes stock behavior [37].  These annotations are chosen 
to provide additional context to support user interpretation of information.  
TreatmentExplorer combines this idea of visualization annotation with the ideas of 
data-driven exploration of care plans for patients as described in [38].  In [38], 
medical histories are mined for similar patients and outcomes of their care plans.  
TreatmentExplorer differs from this work by providing a patient-friendly 
visualization and focusing on the information needs of patients, rather than 
physicians.  TreatmentExplorer also advances care plan visualization research by 
representing more than a single derived metric in its visualization. 
2.6 Summary of Related Works 
TreatmentExplorer is inspired from the results of research in risk communication, 
health literacy, and medical decision aids.  Patients needing to make treatment 
decisions have been shown to be under-prepared to use the empirical evidence 
supporting their treatment options.  Often, patients are not health literate and do not 
have the statistical background to make sense of the information.  Complicating this 




one option for making statistical information easier for patients to understand.  
Research has demonstrated that some graphic formats are better suited for 
communicating probabilities to patients than others.  Other work has shown that even 
physicians struggle with statistics and graphics from time to time.  There is room for 
future investigations to explore the use of interactivity in decision aids and their role 
as patient-physician communication aids.  Techniques from information visualization 
and storytelling research are needed to provide patient-supporting experiences which 









This chapter presents an information-centric, multi-dimensional model for describing 
the content of medical decision aids.  This model was developed as the result of an 
extensive literature review and examining the content of decision aids with respect to 
the variety of information available and its presentation.  It differs from traditional 
methods of evaluating decision aids by avoiding simplistic ratings of patient gist and 
verbatim knowledge produced by a decision aid.  It also avoids addressing healthcare 
business workflows which require examining factors irrelevant to the decision aid 
itself such as how information is updated. 
3.1 Decision Type 
The types of decisions that need to be made in a healthcare scenario range in 
complexity from the very simple to the very complex depending on the treatment 
options available.  The severity of the condition a patient faces will impose emotional 
and social complexities and dramatically affect the time frame in which treatment 
decisions are made.  However, in the context of this model this does not impact the 
classification of the decision presented by a single given decision aid.  That is, this 
model is designed to be condition and stage-of-condition independent.  The risks, 
implications, and consequences of treatment choices to deal with an aggressive cancer 




similarities with the decisions of a patient with a seasonal allergy: multiple treatment 
options may be available, some treatments will be more or less effective than others, 
and repeated attempts to manage the condition may be needed before ultimate success 
is found.  Table 1 summarizes the classifications within the Decision Type dimension. 




Binary A patient may either opt for a 
treatment option or take no 
action. 
A patient may choose to have an 
abnormal growth biopsied or wait 
and observe it for changes first. 
Multi-
Option 
A patient has more than one 
treatment option available, but 
some or all of them may be 
mutually exclusive. 
A patient must decide how to best 
reduce the immediate risk of 
cardiovascular disease through diet, 
medication, or surgery. 
Combination 
Options 
A patient has more than one 
treatment option, several of 
which may increase the 
likelihood of others providing 
benefits. 
A patient looking to reduce a high 
risk of lung cancer decides to stop 
smoking as well as improve dietary 
and exercise habits. 
Continuous 
Management 
A patient has made critical 
decisions about their care and 
now needs assistance in 
maintaining current treatment 
plans. 
A diabetic patient must learn how to 




Binary decision aids are the most common in both research literature and healthcare 
industry use (e.g. figure 9).  They are the least complex and often the decision to be 
made is whether or not a patient elects to undergo the presented treatment option [7] 
[39] [5] [40] [41].  Studies indicate that framing effects of personalized risk and 




whether or not participants opt for treatment [42].  The order in which risks and 
benefits of a treatment are presented has been shown to influence whether or not 
participants felt positively about treatment though the presence of contextual 
information eliminated this bias [43].  Edwards et al. [44] report on a randomized 
controlled trial where diabetes patients chose between a “treatment as usual” 
management plan and a “tight control” plan based on information presented in either 
text, graphical, or text and graphic formats.  Their findings suggest that the format of 
the decision aid had no significant effects on the reduction of decision conflict, 
however participants preferred simple graphics which avoided anchoring information 
and induced information overload.  Other work, however, suggests that intention to 
undertake recommended lifestyle changes was in fact influenced by graphical formats 
but only in participants also receiving high-threat communications [27] [28].  
Graphical decision aids have also been shown to impact the emotional response [45] 
of participants and decrease their passivity in counseling sessions [14]. 
 






Multi-option decision aids are often used when there are multiple treatments a patient 
can consider at once that for varying reasons are mutually exclusive of each other (see 
figure 10).  For example, an early stage prostate cancer patient may be given a 
decision aid to help decide between surgery, radiation, chemotherapy, or simply a 
watch-and-wait strategy [1].  Or, a patient at high risk for breast cancer may need to 
choose the extent of preventative surgery [4].  A key difference between multi-option 
decisions and binary decision is the emphasis of the decision aid: for a multi-option 
decision the information must support comparison between options through its 
format.  This is different from a collection of binary decision aids which each 
individually tell a specific story about a single treatment.  The collection may not 
provide the same information about each option nor will each aid necessarily provide 
measurements which can be compared across decision aids.  Comparison is a difficult 
information process to support in some formats and studies have found that while 
participants prefer simple, familiar graphics, their knowledge as measured by 
question-answer accuracy is higher when more sophisticated graphics are used [1].  
When used as part of consultations, multi-option decision aids have been shown to 
improve knowledge and reduce decisional conflict [15].  When choosing from 
amongst treatments, participants tend to prefer symbols to numbers to represent 
strength of the recommendation or evidence for the treatment and incremental risks 
are consistently perceived as lower in text-only decision aids [20].  Other work has 
shown that both verbatim and gist knowledge are significantly associated with 





Figure 10. An example of a graphic supporting a decision between multiple treatment options 
(from [26]). 
Combination 
Decision aids supporting the combination of treatment options are uncommon in the 
literature.  This may be due to the fact that binary decision aids are much simpler to 
develop and when treatments can be combined to even greater benefit, it seems 
unnecessary to spend time explaining how their interaction will magnify their effects.  
But, they can be particularly effective in communicating the effects of lifestyle 




Jones et al. [13] report on work where 90% of patients in a clinic environment were 
able to make lifestyle adjustments to address their risk of cardiovascular disease with 
the help of a model-based decision aid (see figure 11).  Other systems have been 
successfully built to recommend lifestyle options to patients at risk of cardiovascular 
disease that are in agreement with clinical guidelines and practices [46]. 
 
Figure 11.  An example decision aid which supports exploring a combination of lifestyle and 
treatment options from [13]. 
Continuous Management 
Finally, decisions aids supporting continuous health management are often used in 
situations where patients have chronic conditions necessitating continuous 
management.  Continuous management decisions differ from other types of decisions 
in that each single decision has little impact on a patient’s overall condition.  




these smaller, continuous management decisions has a determining impact on the 
outcome of a patient’s condition.  In these cases, critical decisions have been made 
and a patient has developed a care plan but must now incorporate those decisions into 
daily life.  For example, Chaudry et al. [29] report on a graphics based aid designed to 
help low-literacy diabetic patients make healthier food choices.  Others have 
addressed the needs of informing cardio-vascular patients in learning medication side 
effects and understanding quality of life factors [32].  Adherence to clinical 
guidelines has been found to increase when nurse practitioners are assisted with 
decision aids for patients managing obesity-related health conditions [30].  The 
intention of diabetic patients to adhere to their care plans increased while they 
interacted with game-like decision aids [47].   
3.2 Timescale 
Decision aids often include an explicit time frame in which the outcomes they 
communicate are expected to occur.  Because the majority of decision aids are non-
interactive, these timescales typically do not vary and provide a single snapshot of a 
patient’s risk in an unchanging way.  The impact of timescales on the effect of 
decision aids is an understudied space in the literature.   
Single Projected Point 
In decision aids supporting a single projected data point, a patient’s risk is provided 
for a single point in time regardless of factors that may change during the span of 




cancer risk calculator may provide a patient’s risk of developing pancreatic cancer 
within the next 10 years without showing the effects of lifestyle changes on that risk.  
There is some evidence to suggest that short timeframes are best for achieving risk 
reduction through behavior change [48].  Many decision aids or risk communications 
do not supply an explicit time frame for their data [6].  For example, the National 
Center for Chronic Disease Prevention and Health Promotion reports that reducing 
blood pressure reduces the risk of major cardiovascular events by 50% [49].  While 
useful to know, this gives a patient no indication of the immediacy of the risk 
reduction.  Instead, it is provided as a data point at an implicitly singular future point 
of time. 
 
Figure 12. An example decision aid which reports statistics at a single projected point from [50]. 
Multiple Projected Points 
Decision aids supplying multiple projected points of time present a patient’s risk at 




represented as a continuum.  For example, a patient’s risk of cardiovascular disease 
might be presented as a table with rows reporting the patient’s risk at 5 years, 10 
years, and 15 years form the current date (see figure 13).  Continuous measurements, 
such as mortality rates, are often represented graphically as curves or lines with the 
cumulative measure expressed on the vertical axis and time represented along the 
horizontal axis.  Most often, multiple projected points are used to communicate the 
changing of treatment effects or the evolution of a patients risk over time should no 
actions be taken [20] [10].   
 





3.3 Measurement Types 
A decision aid is designed to convey information to patients in order to help them 
chose their best treatment options.  In order to do this, a variety of measurements may 
be provided so that patients may determine which factors are important for 
themselves.  Measures are provided without priority and it is often the task of the 
patient to choose which are relevant based on personal preferences (see literature on 
patient preference elicitation).  Evidence-based medical practice involves the 
consideration of a great many points of data and each is unique to a patient’s personal 
condition.  This dimension is included in the model as an indication of the design 
complexity of a decision aid.  With all other dimensions identical, a decision aid 
needing to reflect numerous salient measures will be more difficult to design than a 
decision aid detailing a single measurement, say the risk of experiencing headaches as 
a side effect of an oral medication.  Some common measurements such as numbers-
needed-to-treat are found to be easily misinterpreted by patient and physician alike 
[11].  Verbal expressions of risk and other measurements are known to have a wide 
degree of interpretation between physicians and patients [5].  Measurement 
presentation has also been shown to have an effect on interpretation with measures 
shown in familiar formats such as bar charts misinterpreted [27]. 
Survival/Mortality Rates 
For a great many conditions, a patient’s choice of treatment can be the result of a 
single measurement expressing the risk of dying from their given condition or their 




as successful as its resulting survival or mortality rate.  Framing effects have been 
consistently found when equivalent measures are studied.  Patient treatment 
preferences have been shown to vary based on whether patients were presented with 
survival rates or median survival times [1].  Supplying comparative measures such as 
the risk of an average population has been shown to increase the likelihood that a 
patient opts for treatment if the patient’s risk is above average [42].   
Lifestyle Impacts 
The lifestyle impact of a treatment is often overlooked within a decision aid.  Side 
effects may be mentioned, but depending on the source of the decision aid the 
incidence of a given side effect may be unreported or expressed in ambiguous terms 
such as “very low.”  Depending on the severity of the original condition, adverse side 
effects may be considered irrelevant and a treatment choice must be made despite 
them.  For relatively minor conditions however, the risk of a moderately impactful 
side effect such as fatigue or headaches might be a patient’s deciding factor between 
opting for treatment or not. 
3.4 Data Source 
The information presented in a decision aid should come from credible and verifiable 
sources.  The widespread use of the internet by patients in their research puts them in 
danger of encountering inaccurate and unsupported information.  Waters et al. [6] 
report that only 53% of cancer risk assessments found online provide information 




the risk estimate.  In order to reach the best supported healthcare decision that meets 
their needs, patients must have reliable information.  In this dimensional model, three 
sources of information are accepted. 
Literature Summaries 
Summaries of medical literature may be the easiest data sources to obtain and 
redistribute making them a popular choice for data for any decision aid.  Scientific 
studies have the advantage of publications which make providing reference 
information to patients simple.  Clinical trials and other forms of scientific study are 
often summarized and the findings relevant to a particular patient are distilled into the 
content of a decision aid.  Educated patients are free to follow references to the 
original trials and studies for exact information.  While they are relatively easy to 
produce, literature summaries are time consuming and only as accurate as the reports 
they summarize.  They are susceptible to bias if the selected research is not balanced 
or flawed.  They are rarely personalized to any particular patient and are not easily 
updated.  Authors of decision aids may also be forced to reconcile data from 
conflicting studies and risk imposing an interpretation of study data that is 
unsupported.  However, literature summaries are an important information source for 
decision aids as the broad scope of information makes them an ideal starting point for 
patients who have little to no knowledge of a particular condition and need to begin 





For some decision aids, a scientifically developed model accounts for one or more 
condition-specific parameters and classifies a particular patient’s risks based on the 
patient’s personal expression of model parameters (see figure 14).  Breast cancer 
decision aids frequently make use of the Gail Model for patient-specific risk estimates 
[20] [21] [43].  Similarly, cardiovascular disease can be modeled by several systems 
including expert systems using ARIC data [46], the UKPDS risk engine [52] [48], 
and the Framingham Risk model [52] [13] [48].  An advantage of model-backed 
decision aids is that small changes can provide feedback to patients using interactive 
decision aids as demonstrated by Jones et al. [13] and others [28] [45].  Not all 
interactive decision aids invoke models, however.  Ancker, Weber, and Kukafka [53] 
report on the use of interactive graphics for communicating a static value of risk to 






Figure 14.  A model-based system for exploring patient breast cancer risk (from [54]). 
Electronic Health Records 
In large clinic settings, a patient’s personal records may be compared against the 
records of other patients and measures reported in a decision aid are a reflection of 
the outcomes of other patients with similar health records as the given patient.  For 
example, the Hughes riskApp uses EHR data to identify high risk hereditary breast 
and ovarian cancer patients and model their risk of developing cancer across their 
lifetime [55].  Kharrazi [47] reports on the development of an interactive system for 
children with diabetes which uses parent-input reports of compliance as records to 
drive an in-game reward system.  EHRs have the potential to provide the same 
interactivity as scientific models which make them a promising source of data for 




too few records, a decision aid would suffer from the same lack of reliability as 
clinical trial with a small or insignificant sample size.  In this regard, a scientific 
model may be needed to estimate data when real accounts are not available.  With 
access to enough records, however, EHR based decision aids will be able to account 
for a fine level of personalization and capture subtleties of a condition that even a 
finely tuned model may have to abstract away.  Health records may also be patient-
input or reported as in the case of the online health community Patients Like Me [16] 
(see figure 15). 
 
Figure 15.  Screen-capture of information from Patients Like Me [16] which draws its data from 




3.5 Personalization Level 
A decision aid’s relevance is related to its ability to capture a patient’s unique 
circumstances which is significant as the increased relevancy of a decision aid has 
been shown to make health communications more effective [56].  The level of 
personalization supported by a decision aid can range from a series of predetermined 
options a patient may select from to the capacity to include a patient’s entire medical 
history.  This dimension is a measure of the personal relevance of the presented 
information in a decision aid.  With all other dimensions identical, a decision aid 
personalized with a detailed medical history of a particular patient will be more 
relevant to the patient than a decision aid customized on a subset of that patient’s 
history.  In addition to personalizing a decision aid to a patient’s medical condition, 
decision aids may be personalized to reflect a patient’s preferences for treatment.  
Treatments a patient might deem unacceptable for any number of reasons might be 
excluded from consideration entirely.  It could be argued that even a collection of 
entirely generic decision aids is actually personalized as it reflects the options the 
patient who collected the information is willing to consider.   
A patient’s specific risk of a condition is the most common level of 
personalization.  This patient-specific risk can be derived from a wide range of factors 
such as height and weight [30] [46], medications [32] [52], diet plans [32], exercise 
regimens [32] [28], treatment preferences [1] [15] [31] [46], and other lifestyle factors 
[46] [52] [13] [21].  In some cases, these personalizing data are gathered 




commonly entered either by the patient from their own knowledge or with a medical 
professional’s assistance.    
3.6 Information Format 
The most widely studied dimension within this model of decision aid content is the 
information format of a decision aid.  With the utilization of the internet, a broad 
range of media has become available for the communication of patient treatment 
options.  Rather than attempting to capture all the possible media now used for the 
production of decision aids, this dimension will focus on broad categories of 
presentation.  Decision aids may belong to one of several categories summarized in 
Table 2.  The same data may be presented in multiple formats and a number of 
decision aids may be designed to support patients making the same decision.  A 
patient may be given multiple decision aids of differing formats in order to make the 
information as clear as possible or to leverage the advantages of some formats over 
others.  The classifications within this dimensional model refer to the format of a 






Table 2. Information Formats Used by Decision Aids 
Format Description Example 
Text Treatments, risks and outcomes 
are expressed in written formats 
without graphics or 
augmentation. 
A patient is given a report to use in 
determining whether or not to 
undergo a medical procedure. 
Graphics Treatments, risks, and outcomes 
are expressed in a graphical 
format such as bar charts, pie 
charts, pictographs, etc. 
A patient is given a booklet of 
infographics which portray the risks 
of experiencing side effects of a 
possible medication as a series of bar 
charts.  Each chart represents a side 
effect and each bar of each chart 
represents a year of treatment. 
Text + 
Graphics 
A decision aid contains both text 
(as described above) and 
graphics (as described above) 
A patient is given a report with 
particularly salient study results 
called out in a table and risks 
communicated through pictographs. 
Animation A decision aid uses graphics 
which are animated to reflect 
changing measures or guide 
patients in understanding one 
graph’s relation to another. 
A patient is given a video which 
narrates a smoker’s cumulative risk 
of acquiring lung cancer as a series 
of pictographs.  Each step in the 
animation alters the data in the 
pictograph by one year at a time. 
Interactive A combination of text, graphics, 
or animation is available which 
patients may manipulate through 
a series of controls and observe 
the effects on relevant data. 
A patient’s risk of cardiovascular 
disease is assessed based on current 
lifestyle factors and then the patient 
selects a number of lifestyle 
adjustments to observe how those 
adjustments affect projected risks. 
Text 
Text-only decision aids are commonly found in research literature where they are 
very often used as a control condition in a randomized trial.  There is evidence to 
suggest that patients prefer other formats, particularly those that provide immediate 




which has been shown to hinder both patient and physician alike [11].  Some work 
has even found that numeric text alone produces low knowledge in comparison to 
pictographs [50].  Other studies have suggested that the believability of data was 
perceived as greater in decision aids which contained graphics instead of just text [28] 
and that risk presented as text-only data is often overestimated [20].   
Graphics 
The study of graphics as decision aids has provided evidence that features which 
support the accurate or correct interpretation of data are different from those that 
prompt behavior modifications [7] (see figure 16 for commonly studied graphics).  
Numeracy and graphicacy have been repeatedly shown to affect the accuracy of 
patient understanding [4].  Pictographs have been shown to help patients attain higher 
risk comprehension, particularly those with low-numeracy [26].  Factors such as 
horizontal layout and shading have been investigated for their impact on graphic 
understanding [40].  Familiar graphics are often preferred based on qualitative reports 
but can also lead to less accurate knowledge [44].  There is danger in applying 
unfamiliar graphics such as funnel plots which allow patients to apply their own, 
possibly incorrect, interpretation to data [27]. 
The combination of text and graphics in a decision aid has some mixed 
results.  Participants have reported information overload when risk communicated 
through graphics is augmented with additional information as text [44].  Other work 




with higher verbatim knowledge in patients but at the cost of lower gist knowledge 
[26]. 
 
Figure 16.  Multiple graphic formats evaluated by Brown et al. in [4] 
Animation and Interaction 
Animated and interactive decision aids are less prevalent in research literature but 
their effect has been encouraging.  Low-numeracy participants have been found to 
report higher risk-feelings than high-numeracy patients except when using interactive 
graphics such as figure 17 [53].  Uncertainty of cancer risk was effectively 
communicated through a dynamic visual format by Han et al. in [25].  Interactive 
decision aids have also consistently led to more expressed emotional responses 




empowerment [45].  Participants not making use of interactive features report lower 
intentions to make lifestyle changes or adhere to care guidelines when compared with 
participants in interactive conditions [47] [13].  One barrier to the adoption of 
interactive decision aids is studied by Xie, Watkins, and Huang [41] who indicate that 
the controls used by interactive decision aids are frequently non-intuitive to target 
populations such as older adults.  Some evidence has also suggested that interactivity 
can distract patients from understanding relevant information [57]. 
 




3.7 Multi-Dimensional Model Summary 
The content of medical decision aids can be described through six independent 
dimensions: decision type, timescale, measurement types, data source, personalization 
level, and format.  The most common combination of dimensions in published 
research is that of binary, single projected point of time, single measurement decision 
aids derived from literature summaries and without personalization presented in a text 
or basic graph format.  This prevalence of simple decision aids does little to address 
the information needs of patients who may have more complicated decisions to make 
over the course of longer timescales or when multiple data points need considering.  
Electronic health records are becoming more available as data sources which could 
enable a greater degree of personalization for patients which in turn, would increase 
the relevancy of decision aid content.  Finally, animation and interactivity is grossly 
understudied.  The internet provides a platform which supports interactivity and with 
more patients turning to the internet to search for information, research is needed to 
understand how such interactivity and animation can be used to better support 




Chapter 4: TreatmentExplorer Design and Expert Review 
 
 
After analysis of the design space and the gaps exposed by the Multi-Dimensional 
Model several observations were made.  It became clear that decision aids capable of 
supporting the exploration of multiple treatment options were lacking.  Further, many 
decision aids did not address issues of patient risks and outcomes over time.  Single 
measurements were the most common and side effects of treatments were rarely 
quantified when mentioned.  Much of the research reviewed did not discuss effects of 
personalized decision aids apart from the consensus that personalized decision aids 
were more relevant to patients.  These observations inspired the TreatmentExplorer 
prototype (demo and code can be found at 
http://www.cs.umd.edu/hcil/treatmentexplorer/). 
4.1 Design Goals 
As discussed in Chapter 1, the challenges faced by patients choosing a treatment 
option present several design goals which include: 
1. Multiple-Treatment Options: the prototype should support patients comparing 
multiple treatment options. 
2. Multi-Measurements: the prototype should go beyond representing only a 
treatment’s success rate and express other details about a treatment such as its 




3. Multiple-Projected Points of Time: the prototype should capture the changes 
in patient outcomes that can be expected over the entire course of treatment, 
rather than at a single sampled point of time. 
4. Personalized Outcomes: the prototype should represent personalized outcomes 
that are most likely to be experienced by a given patient.  This includes 
leveraging the outcomes from other patients to make the decision aid reflect 
the most realistic outcomes possible. 
4.2 Early Prototypes 
Early designs for the TreatmentExplorer prototype were more ambitious in the scope 
of their visualizations.  In particular, they attempted to show information for all 
available treatments at once.  Ultimately, simpler visualizations depicting details for a 
single treatment where chosen to avoid risking information overload. 
Basic Graphics 
A clear starting point for TreatmentExplorer involved the use of several basic graphs 
commonly used in all forms of media that patients would already have exposure to 
and be familiar with.  There is extensive research to support the efficacy of certain 
basic graphs in isolation and in combination with text-based content.  A partial 





Figure 18. A partial, early decision aid prototype using multiple basic graphs to communicate 
cancer risk and side effects for three treatment options. 
Figure 18 shows six basic graphs, both bar and line, which communicates the risk of 
cancer for three hypothetical preventative cancer treatments and the associated side 
effects.  These graph choices have been studied in risk communication literature for 
their ability to convey varying measurements to the average patient.  This partial 
prototype illustrates several design challenges, however.   
To begin with, multiple graphs are needed to convey multiple measurements. 
Bar graphs are ideal for conveying the difference in magnitude of a single 




measurements such as treatment popularity and a single risk calculation for a single 
point of time.  A patient could compare these two single measurements across three 
treatments easily.  However, bar graphs are not generally able to convey time as well 
as other types of graphs (such as line graphs).  To communicate how cancer rates vary 
across time, another graph such as a line chart or augmentation with other visual 
embellishments such as animation is needed.  Line charts are excellent for showing 
time trends of a single measurement across time.  But multiple line charts are required 
to show the trend in onset of cancer and side effects across time.  Using a single line 
chart would impose a great deal of clutter and confusing multiple instances of a 
treatment in a single graph. 
 A second design challenge is that it is difficult to obtain a clear understanding 
of a single treatment as a whole.  This series of graphs is designed to support 
comparing multiple treatments against each other one metric at a time.  The details of 
a single treatment are spread to multiple locations.  A patient using such a decision 
aid must assemble various pieces of information from many places to understand a 
treatment as a whole. 
All Treatments 
Initially, all information about all treatments was available to a patient in a single 
visualization.  Comparisons could be made across treatment representations and 
coordinated interaction would highlight the same data points across all treatments at 
once so patients could easily find a data point’s representation.  A partial prototype of 





Figure 19. An early prototype displayed all treatments simultaneously for rapid comparison 
across treatments at a glance. 
This prototype has the design benefit of enabling comparison across treatments 
rapidly as well as providing a complete description of a single treatment which 
overcomes the two drawbacks of the basic-graphs prototype.   
This partial prototype is not without its own drawbacks, however.  Because all 
treatments are represented in the visualization at once, there is little room for 
treatment details.  For example, the vertical sizing of each treatment bar represents 
the relative popularity of the treatment.  However, because of the vertical stacking of 
each treatment this is difficult to compare when all treatments are similarly popular.  
Further, there is no room for a vertical axis to report exact numbers of patients who 
experience a condition or side effects for each treatment. 
A second drawback to this design is the real potential for information 
overload.  Research has shown that many patients face numeracy and graphicacy 




be difficult for a patient to not know where to start reading this novel visualization.  
Vertical sizing shares some properties with bar charts; however the additional 
horizontal representation of time could confuse patients.  Interactivity could help by 
illuminating and reinforcing which measurements are related across treatments but 
would still not be enough to help an overwhelmed patient know where to focus first. 
4.3 Description of TreatmentExplorer 
The final TreatmentExplorer prototype reuses the treatment representation from the 
All Treatments prototype but scales down the visualization such that a single 
treatment is displayed at a single time (see figure 20).  The vertical and horizontal 
axis can thus be repurposed to display treatment-specific details such as the exact 
number of patients choosing a treatment and the timescale most relevant to the 
treatment.  Animated navigation between treatments preserves the ability to compare 
treatments even though the information of only one treatment is displayed at a time.  
The TreatmentExplorer prototype thus fits into the following dimensions of the multi-





Figure 20.  The final TreatmentExplorer prototype includes multiple measurements for each of 
multiple treatments across multiple points of time.  Interaction and guided narration support 
patient understanding of treatment information. 
Electronic Health Record Data-Sourced 
The TreatmentExplorer prototype was developed using synthetic Electronic Health 
Records in a format similar to the records used in EventFlow [58].  By opting for 
EHRs as a data source, the TreatmentExplorer prototype can be easily updated to 
reflect the most current data relevant to a condition and patient.  It also enables 
TreatmentExplorer to support a great variety of conditions.  Deployed in a clinic 
environment, a fully-operational system would be useful to all patients.  For ease of 
development, hand-built synthetic datasets were used and designed to exhibit specific 
characteristics such as varying treatment popularity, varying reports of side effects, 




either based on published statistics about the prevalence of certain conditions (such as 
breast cancer [59]) or completely fictitious. 
Patient-Specific Personalization 
Because EHRs are used to drive the content of TreatmentExplorer, a physician/patient 
team can select only the most relevant patient records to visualize.  A search interface 
would allow for the custom input of patient age, gender, and vital information.  
Alternatively, direct input from a patient’s own health records could be used and 
similar patients found through algorithms such as those in [38].  The resulting 
treatment visualizations will thus display only the most relevant outcomes to a 
patient. 
Multi-Treatment Option 
TreatmentExplorer supports the visualization and comparison of multiple treatment 
options.  This is a relatively unexplored part of the design space as revealed by the 
dimensional model discussed in Chapter 3.  By supporting multiple treatment options 
and their comparison, patients using TreatmentExplorer are relieved of the cognitive 
burden of assimilating data from multiple different decision aids.  Patients are able to 
explore the relative differences between treatments as well as learn the details of 
individual treatments as a whole.  Navigation between treatments is enabled via a 





Figure 21.  Navigation in TreatmentExplorer is enabled through buttons.  The navigation panel 
also displays information about the relative popularity of each treatment. 
Initially, when the TreatmentExplorer prototype is loaded in a web browser, neither 
the visualization nor the treatment specific highlights are visible.  Patients are instead 
prompted with a mostly-empty page to select from one of their treatment options.  
This overcomes one of the design challenges of the previous prototype by providing 
patients with a clear starting point for using the visualization.  Selection of a 
treatment is shown with a selection color and a patient’s exploration of a treatment 
marked by an animation-replay button once the patient has viewed the narrative for a 
selected treatment as shown in figure 22.  Additionally, the navigation panel 
graphically presents the relative popularity of treatments within the represented EHR 
data.  The accompanying bar graph displays popularity on the vertical axis as well as 
the exact number of patients choosing that treatment in the button label.  Animated 
transitions between treatments, both rapid and with guided narration, enable the 
comparison between treatments even though the details of one treatment are 





Figure 22.  A selected treatment is visually distinguished from the other available treatments 
with color and labeling. 
Multi-Measurement Display 
TreatmentExplorer also represents multiple relevant measurements and details of a 
treatment which further explores the design space outlined in Chapter 3.  The 
proportion of patients remaining healthy after treatment, experiencing a specific 
condition, and afflicted by side effects are all represented in the visualization.  
Additionally, the average onset time of a condition is available and an exact 
cumulative distribution of onsets is available as an advanced option.  Information 
about side effects associated with treatments include the number of patients reporting 
each side effect as well as the date of the earliest reporting and the date of the last 





Figure 23 The TreatmentExplorer visualization displays the relative portion of healthy vs. 
condition-developing patients who have chosen a given treatment as well as the average time to a 
condition's onset and any side effects reported. 
The number of patients choosing a given treatment is represented along the vertical 
axis of the visualization.  Time is represented along the horizontal axis with duplicate 
axis labels to assist patients in making judgments about the timing of depicted events.  
A consistent, bright green color is used to represent the proportion of patients who 




time period.  A grey color and accompanying dark grey solid bar represent the 
proportion of patients who eventually develop a condition and the average time at 
which they develop a condition.  The exact cumulative distribution of condition 
onsets is available as a line overlay in this region as an advanced option.  These 
measurements were selected to provide information relating directly to success and/or 
mortality rates of conditions and describe the overall efficacy of a treatment.   
Side effects are also shown in the visualization and appear as overlays using 
an orange-purple color scale to distinguish them from the healthy and afflicted 
groups.  Side effects are included in the visualization to provide information on 
potential lifestyle-affecting complications associated with a treatment.  Because both 
healthy and afflicted patients may report side effects, side effects are positioned 
equally atop the healthy and non-healthy regions.  Accompanying text highlights 
reinforce the measurements represented on the visualization and in-visualization text 
tips further support patients’ interactive exploration of the represented data. 
Multiple Points of Time 
The horizontal axis of the TreatmentExplorer visualization is derived from the length 
of time captured by the EHRs.  Each treatment is displayed using the same horizontal 
scale based on the length of the longest record available in the visualization.  This 
allows patients to compare the anticipated time of condition onset as well as the 
reporting of side effects along a consistent axis between treatments.  It also provides a 
consistent context for patients to understand how well outcomes of patient with their 




Animated Graphics and Text with Guided Narration 
One of the under-studied spaces identified by the dimensional model was that of 
interactive decision aids.  Because the TreatmentExplorer visualization is a novel 
design, an animated, guided narration has been included to both teach patients how to 
interpret the visualization and to explain the treatment outcome data itself.  This 
guided narration makes use of synchronized text captions and transition of 
visualization elements to explain each piece of the visualization (see figures 24 
through 29).  The narration begins when a patient selects a treatment to explore and 
includes the following steps: 
1. A ‘Start Screen’ appears and explains that the visualization will update to 
show the outcomes of patients in the treatment group and how long the 
records of those patients extend into the future. (Figure 24) 
2. The proportion of the visualization representing patients of the treatment 
group who are healthy appears and is sized appropriately. (Figure 25) 
3. The proportion of the visualization representing patients who eventually 
develop the given condition appears and is sized appropriately. (Figure 26) 
4. A solid bar appears in the region representing the patients who develop a 
condition.  This bar shares the height of the region but is a fixed width.  This 
bar represents the average onset of the condition and moves to the appropriate 
place along the horizontal axis. (Figure 27) 
5. A uniquely colored, semi-opaque region representing a side effect of the given 
treatment appears.  This region moves vertically such that half the region lies 




patients.  The width of the region is such that the left edge aligns with the 
point along the horizontal axis representing the first report of the side effect in 
the treatment group.  The right edge of the region aligns with the date of the 
last report within the treatment group. (Figure 28) 
6. A concluding screen confirms that the narration has finished and prompts the 
user to replay the same narration, explore the current treatment, or select a 
new treatment. (Figure 29) 
While the visualization plays through its animations, the treatment highlight list is 
kept synchronized.  The explanatory text reporting exact statistics begins with the 
exact statistics of the healthy patients (step 2, Figure 25) and provides accompanying 
captions through all side effects (step 5, Figure 28).  Additionally, captions appear in 
the center of the visualization as the animation plays.  The in-visualization captions 
display the same text as the treatment highlights and can be moved below the 
visualization through a toggle available below the treatment highlights list. 
 Each step of the narration is cued by the patient by clicking in the 
visualization with the mouse or by a key press so that patients can take as much time 
to read captions and study the visualization as they want.  Each step of the narration 
begins with the display of the text highlights and captions and the animation of the 
step begins after a brief delay.  When the animation has completed for a step, a 
prompt appears to alert the patient that they may continue when they are ready.  





Figure 24. Animation Step 1: A patient selects a treatment from their options and is shown a 
start screen explaining the visualization update and describing the extent of the treatment data. 
 
Figure 25. Animation Step 2: The proportion of patients who remain healthy after a treatment is 





Figure 26. Animation Step 3: The proportion of patients who eventually develop a condition is 
animated onto the visualization with synchronized explanatory text. 
 
Figure 27. Animation Step 4: A solid bar representing the average onset of a condition appears 





Figure 28. Animation Step 5: A rectangular region representing the side effects of a treatment 
animates onto the visualization over the range of time that reports of the side effect appear and 





Figure 29.  Animation Step 6: An ending screen informs the patient that the guided narration 
has finished and prompts them to replay the narration, explore the visualization, or to choose a 





Figure 30.  Once the animation has finished, patients can explore the visualization with the 
mouse.  Pop-ups with explanatory captions from the guided narration appear as patients mouse-
over visual elements.. 
Rapid Transition for Faster Comparisons 
During pilot testing of TreatmentExplorer, almost all of the participants making use 
of the fully featured, animated version of TreatmentExplorer made the same request: 
after commenting on how useful the guided narration was, they asked for a way to 
quickly move to the end of the animation so that they could refresh their memory 
faster.  They indicated that once they had seen the full narration the first time, it 
would be more useful if they could quickly move between treatments without having 
to pause for the narration. 
In response to these requests, a shortened version of the animated transition 
between treatments was developed and replaced the default transition between 




guided narration plays.  Subsequent selections of that treatment use the shorted 
version.  The shortened narration follows steps 2-5 of the full narration.  That is, the 
healthy region is resized, the afflicted region is resized, the average onset bar is 
moved, and then the side effects are transitioned.  However, in the shortened 
transition, these steps play as a sequence without pausing for user interaction.  The 
duration of the animations is also shortened such that the entire sequence completes 
in one third of the time of the full animation (not counting pauses for user 
interaction).  Further, the text highlights for a treatment appear at once after the 
shortened animation sequence plays.  In-visualization captions are not shown during 
the rapid animation, but after the transition the in-visualization captions become 
available as patients explore the treatment. 
Advantages of TreatmentExplorer 
To summarize, the TreatmentExplorer prototype offers the following advantages 
towards addressing the design goals of Chapter 1: 
 Multiple Treatment Options are Shown:  Patients are able to explore multiple 
treatment options and compare them in the same decision aid.  Because 
treatments are visualized individually, there is space for a complete treatment 
picture which includes success rate, onset of symptoms/condition, and 
individual side effects associated with a treatment. 
 Personalized by Relating to Similar Patients:  By drawing its data from EHRs 
(presumably from local clinic systems), patients are presented with 




similar patients receiving treatment from similar clinics.  This provides a 
credible source of information but also entertains the possibility of relating 
patient testimonials and community support to patients making healthcare 
decisions. 
 Data is Organized with Narration: Patients in the process of learning about 
their health situation and their treatment options are supported in organizing 
the relevant data.  Not only are the important facts about a treatment 
introduced in a structured way, but their visual representation is explained as 
it appears in the visualization. 
4.4 Software Engineering Design to Support Flexibility 
TreatmentExplorer is intended to be the patient-user facing interface to a larger 
clinical system with access to large numbers of electronic health records.  As such, 
there are several technical challenges that needed to be overcome in its design. 
Input Source 
Ultimately, TreatmentExplorer will have access to a database of patient health 
records.  To simulate this source of individual records during development, two text 
files serve as input for the system.  The first file simulates individual patient health 
records and is based on the format used by the EventFlow system [58].  Patient 
records appear as a series of events with one event on each line of the file and 
information about the file tab delimited.  Event details include the patient’s id, the 




case of interval-based events).  The second input file is a meta-information file.  This 
meta-file contains the name of an event and the category of the event.  This category 
information instructs TreatmentExplorer on the interpretation of the event.  This 
interpretation affects how events are counted and used in the statistical calculations 
performed by TreatmentExplorer and how the event is represented in the resulting 
visualizations.  The categories used by TreatmentExplorer are summarized in table 3. 
Table 3.  Event Categories used by TreatmentExplorer 
Category Interpretation 
Diagnosis Beginning of patient records.  Used to 
determine the starting date of a patient’s 
records and events. 
Treatment Name of a treatment option represented 
by patient records.  This is an interval 
event representing how long a patient 
underwent the named treatment. 
Adverse Name of an adverse side effect of a 
treatment.  This is a complication 
associated with a treatment that is 
independent of any primary symptoms or 
conditions a patient has been diagnosed 
with. 
Condition Name of a primary symptom or primary 
condition a patient has been diagnosed 
with and is seeking treatment fore. 
 
By using text files, the TreatmentExplorer prototype can be used to visualize any 
arbitrary condition with any number of treatment options.  This makes 





Associative arrays are used to store patient health records.  These arrays are first 
accessed by patient id and entries are also associative arrays keyed by event start date.  
Supporting associative arrays map conditions and adverse side effects to the ids of 
patients who report those events in their records. 
Visualization Supporting Algorithms 
The data structure containing health records and keyed by patient id and the structure 
associating treatments with the ids of patients undergoing that treatment is built 
through the following algorithm (in pseudo code): 
for each Patient Record as {id, event, start, end}: 
 if PatientRecords[id] is undefined 
  PatientRecords[id] = {} 
 if PatientRecords[id][start] is undefined 
  PatientRecords[id][start] = [] 
push {id, event, interval, start, end} to PatientRecords[id][start] 
if EventPatients[event] is undefined 
 EventPatients[event] = {} 
if EventPatients[event][id] is undefined 
 EventPatients[event][id] = [] 
push {start} to EventPatients[event][id] 
 
In this algorithm, ‘interval’ is a Boolean value used to indicate whether or not a valid 
end date for the event was part of the record as it was read from the event text file.  
Point events have undefined end dates in the input text file and will not have an ‘end’ 
value pushed to the PatientRecords structure.  This first data structure building loop is 
needed to collect patient records in order of starting dates which is not required or 
enforced in the input file.  Date normalization is performed as part of the algorithm 




date normalization converts all dates to a difference between the beginning of a 
treatment and the event. This allows TreatmentExplorer to represent patient records 
equally when they may come from very different periods of time.  Date-based data 
points represented in the TreatmentExplorer visualization are thus relative to the 
beginning of treatment. 
The visualization-supporting data structure is built through the following algorithm 
(in pseudo code): 
visData = [] 
for each Treatment in Treatment List 
 count = 0 
 datum = {} 
 TreatedPatients = EventPatients[treatment] 
 for each PatientId in TreatedPatients 
  count = count + 1 
  first = null 
  last = null 
  patientConditions = [] 
  patientAdverses = {} 
for each Date in PatientRecords[PatientId] 
 if Date is after last 
  last = Date 
 else if Date is before first 
  first = Date 
   for each Record in PatientRecords[PatientId][Date] 
    if Record.event is Condition 
     push Record to patientConditions 
    else if Record.event is Adverse 
push Record to 
patientAdverses[Record.event] 
   difference = last – first 
   push difference to datum.durations 
   for each Record in patientConditions 
    difference = Record.start – first 
push difference to datum.conditions 
   for each Record in patientAdverses 
    difference = Record.start – first 
    push difference to datum.adverses[Record.event] 
 datum.patientCount = count 




 datum.durationMax = Max(datum.durations) 
 push datum to visData 
Interface Implementation 
In order to provide patients with a readily accessible decision aid, the 
TreatmentExplorer prototype has been implemented as an interactive website using 
HTML and JavaScript.  The D3 JavaScript library [60] is used to provide SVG based 
visualization support.  By building TreatmentExplorer as a web-based decision aid, it 
allows patients to access the decision aid from convenient locations during and after 
consultations with their physicians and healthcare providers.  It also eliminates the 
need for software installation and maintenance duties to be forced upon patients.  
TreatmentExplorer can access remote record systems and provide patients the most 
important information from a wide range of sources. 
Technical Limitations 
TreatmentExplorer has been designed to be adaptable and generalizable to a wide 
variety of conditions.  However, in its early development state, there are some 
simplifying assumptions made by the data structures and algorithms.  It is assumed 
that there is only one primary symptom or condition of concern to a patient.  While 
TreatmentExplorer can represent an arbitrary number of treatment options, it is 
assumed they all relate to the treatment of a single condition.  Treatments are 
assumed to be mutually exclusive and modifications would be needed for both the 
algorithms and visualization to accurately represent patient records of patients 




adverse side effect in the guided narration though this is not enforced in the current 
data structures or algorithms.  Future research will need to explore options for 
presenting multiple side effects and conditions on a single visualization. 
     
4.5 Expert Review Process 
Four experts in the fields of medicine, public health, and risk communication were 
given a demo of the TreatmentExplorer prototype and interviewed for design 
improvements.  Experts were recruited through mutual contacts based on their 
research focus and working experience.  These demo and interview sessions were 
conducted at the experts’ work location and lasted an hour.  Suggestions and feedback 
were then incorporated into the next version of TreatmentExplorer before it was 
shown to the next expert.  Consensus between experts in feature suggestions and 
improvement was used to decide which improvements to make.  Along with interface 
and feature suggestions, experts were asked about the possible role of a fully 
developed system in a professional medical setting.  Evaluation strategies were also 
discussed for evaluating the efficacy of such a system. 
Expert Review Scenario 
For demonstrating TreatmentExplorer to expert reviewers, the following scenario was 
given as a typical use-case: 
A patient, Donna, is 60 years old and has a family history of breast 
cancer.  She's also recently been tested positive for the BRCA1 gene 




now deciding whether or not she should undergo surgery or take 
medication to reduce her risk. 
The demonstration dataset was comprised of synthetic data.  It simulated 90 patient 
records with rates of cancer and side effects derived from publically available breast 
cancer fact sheets available from the National Cancer Institute [51] and the Susan G. 
Komen Breast Cancer Foundation [61]. Three treatment options were available: 
routine care (no treatment), medication (based on Tamoxifen), and surgery (based on 
double prophylactic mastectomy). 
4.6 Improvements Resulting from Expert Reviews 
Each expert received TreatmentExplorer very well with positive comments ranging 
from “an excellent start” to “this is gorgeous”.  Frequently, experts asked for a 
version of TreatmentExplorer which they could use to investigate their own data.  In 
the resulting discussions, several desired improvements were made clear.  These 
suggestions centered primarily on improving the visualization and making it more 
accessible to patients.  The improvements with the greatest usability impact were 
immediately implemented.  Several other feature requests from experts are in 
consideration for future development.  The immediately implemented improvements 
include: 
Add a representation of the distribution of condition onsets to the display as an 
advanced option instead of only providing the average. 
One expert who was a practicing medical professional indicated that physicians 




would insist on having the distribution of cancer reports from the entire treatment 
group available.  This request was made by other experts though others with 
experience in public health and communication suggested that such detailed 
information be kept as an advanced option.  Alternatives to a distribution were 
discussed such as a median mark with quartile range markers similar to a standard 
box-and-whisker plot or a line graph representation showing the cumulative reports of 
a condition throughout the represented range.  After discussion with the experts and 
the drafting of possible representations, it was decided that the line graph showing the 
cumulative reports of condition onsets was the best solution.  This line would overlay 
the section of the visualization representing afflicted patients and accompany the bar 
marking the average onset time when in use. 
Provide color scales suitable for patients with colorblindness 
Several experts viewed an early prototype of TreatmentExplorer and remarked that 
the colors used to represent condition onsets and side effects were too similar.  One 
expert was himself colorblind and had difficulties perceiving the range of time that 
certain side effects were reported in the demonstration scenario.  The color scheme of 
the prototype was immediately revised to use more contrasting colors suitable for 
colorblindness and acceptable when converted to grayscale.   
Use simple animations so that patients only need to follow one moving object 
Early versions of TreatmentExplorer’s guided narration transitioned the sizes of the 
representation of healthy patients and condition-afflicted patients when switching 
from one treatment to another.  This was intended to provide a means of comparison 




different treatment groups.  Experts remarked, however, that with accompanying text 
transitioning as well that there were too many moving parts to the visualization and 
that patients might feel overwhelmed at first.  To reduce the barrier to use, animations 
accompanying the guided narration were simplified so that all treatments began from 
the same, empty visualization area.  Each component of the visualization was 
removed at the start of narration and re-appeared one at a time as the narration 
progressed. 
Include a description of the limitations of the represented health records  
To accompany the guided narration, it was suggested that a beginning text screen 
provide a high level disclaimer and description of the records the visualization 
represented before the narration began.  This information would help patients 
understand what the visualization was capable of reporting and what the limitations of 
the dataset were. 
Report all data from same maximum-scaled time-frame  
Early versions of TreatmentExplorer ended the representation of a treatment group’s 
records at the average onset of a condition.  This was intended to reinforce the 
difference in onset times between treatment groups by horizontally sizing the groups’ 
representations.  Several experts indicated that this might be confusing to patients for 
several reasons. It could be interpreted as missing information or as extremely 
adverse outcomes such as deaths in the treatment groups.  It was also a representation 
contrary to traditional risk communication which often provides data for specified 
and consistent time periods such as 10 years after treatment.  To avoid confusing 




dataset and an additional vertical bar is used to indicate the average onset time of a 
condition. 
Grow visual display from bottom of the chart, rather than the top 
One expert pointed out that the graphics patients are most experienced with and are 
found in most decision aids are oriented with their y axes beginning at 0 at the bottom 
of a graph and increasing vertically towards the top.  The original layout of the 
TreatmentExplorer visualization had both the x and y axes beginning with 0 located 
in the top left corner.  This was intended to avoid confusing patients with different 
values of axes located close together.  However, it was decided after discussion that 
re-orienting the y axis to its customary 0-at-the-bottom would be less confusing.  
Additionally, a duplicate x axis was added to the bottom of the visualization to 
reinforce the difference in scales.  As the guided narration progressed, then, vertical 
space in the visualization was filled from the bottom and growing towards the top.  In 
this way, a growing portion of healthy patients could be associated with a better 
treatment success rate. 
Overlap side effects so that they overlay both health and condition onset patients 
in the visual display 
Initially, the reports of side effects of a treatment were handled as a group of patients 
separate from those patients who eventually developed a condition.  One expert 
indicated that this would be misleading to patients who might assume that treatment 
associated side effects were not reported by patients who developed a condition.  To 
avoid misinforming patients, the drawing of side effect representations was revised 




representation of patients who developed a condition.  In this way, side effects and 
their reports would be shown as independent of whether or not patients developed a 
condition and associated with the treatment group as a whole instead. 
4.7 TreatmentExplorer Role in Decision Making and Evaluation 
Strategies 
Among the improvements to the visualization component of TreatmentExplorer, 
several experts discussed its possible role in a clinic environment.  It was frequently 
remarked that the TreatmentExplorer visualization by itself could be too 
overwhelming for the average patient.  However, several of TreatmentExplorer’s 
features improved the accessibility.  Particularly, the guided narration served to both 
teach patients about how to use the visualization as well as inform them about their 
treatment options.  The replay option would further support patients by allowing them 
to watch and re-watch the narration until they felt comfortable with all the 
information.  The experts were well in agreement that the ideal use case for 
TreatmentExplorer would begin with both the patient and their physician setting up 
the treatment options together in an initial consultation.  During such a consultation, 
the patient could be introduced to TreatmentExplorer and have any initial questions 
answered.  The patient would then be given access to TreatmentExplorer to use on 
their own time after the consultation so that they could continue to view the guided 
narrations and explore their chosen treatment options. 
 In discussions about evaluations, the experts suggested a few possible 




physicians in a mock-consultation setting for a small series of case studies.  Another 
alternative suggested was to focus on a single condition using a real dataset of 
anonymized patient records of patients with a specific heart-related condition and to 
discuss TreatmentExplorer with experts from advocacy and support groups relating to 
that condition.  Both these evaluation plans would provide valuable feedback from 
real patients and potential users of TreatmentExplorer and future work will likely 
involve such case studies.  A third evaluation option discussed involved the 
controlled study of TreatmentExplorer and the comparison of patient performance on 
a basic knowledge test using TreatmentExplorer with patient performance when using 
a comparative baseline decision aid.  This third option would allow for quantitative 
data to be collected about which features were responsible for patient understanding 
(or misunderstandings) of treatment options.  A preliminary evaluation following the 
intent of this controlled user study is described in the next chapter. 
4.8 Improvements Resulting from Participant Feedback 
A pilot study of eight participants (see chapter 5) was conducted to elicit feedback 
about usability issues before a full evaluation of TreatmentExplorer.  These 
participants were recruited through a convenient sample of fellow HCI researchers 
but none had prior experience with TreatmentExplorer.  They were asked about 
which features they found most helpful during a debriefing at the end of their pilot 
study session.  Participants using the full- featured version of TreatmentExplorer all 
made the same request at some point in their debriefing leading to a subtle but critical 




Allow patients to quickly scan their treatment options without viewing the entire 
guided narration. 
Originally, the default behavior of TreatmentExplorer was to transition between 
treatments by guided narration.  This animation served two purposes: 1) to teach users 
how to read the visualization and 2) to emphasize each important measurement 
related to a treatment.  A replay feature was included early on to allow patients to re-
watch the entire narration as many times as they wished.  However, pilot participants 
felt the full narration interfered with their ability to quickly compare treatments.  In 
order to preserve the benefits of animation in emphasizing treatment differences, a 
faster animated transition was introduced to be the default transition between 
treatments.  When a treatment is first viewed, the complete narration with pauses for 
user control and in-visualization text or captions is used to introduce the patient to 
both the treatment and the visualization.  The next time the same treatment is 
selected, the sped-up transition was used.  The sped-up transition followed each step 
of the full animation but took 1/3 the duration.  Additionally, pauses for user control 
were removed and in-visualization text or captions were hidden.  With this sped-up 
transition, patients would still see each treatment difference emphasized as they 
explored their treatment options.  The replay button remained available so that 
patients can always replay the guided narration.  This sped up-transition is only 
enabled on a treatment after a patient views the full, guided narration once.  In this 
way, patients still experience the benefits of the guided narration but rapid 




4.9 TreatmentExplorer Design and Expert Review Summary 
The TreatmentExplorer prototype is an interactive, web-based decision aid which 
utilizes the D3 JavaScript library [60] to provide guided narration and visualization 
support to patients.  It is capable of representing an arbitrary number of treatment 
options with at most one adverse side effect.  The current design represents a single 
treatment at a time so that details about a treatment can be represented in the 
visualization.  Transitions between treatments enable comparison across treatment 
options.  This design overcomes the challenges presented by both basic graphs and 
design alternatives which attempt to represent all treatments at once.  Four experts 
were interviewed individually for an hour and provided feedback on the role of 






Chapter 5:  Preliminary User Evaluations 
 
 
A preliminary usability evaluation was conducted to evaluate the efficacy of the 
feature-complete TreatmentExplorer prototype.  This study was designed to measure 
patient knowledge gains when using TreatmentExplorer over a text-only decision aid 
similar to those found online for comparing treatment options.  The study procedure 
was inspired from discussions with experts in the field of public health and medicine 
as well as the controlled studies conducted in the research reviewed as part of the 
earlier literature review.  A pilot study of eight participants was first run to determine 
the best procedure for measuring the dependent variables.  The results of this pilot 
study were used to refine the procedure for a full, follow-up evaluation. 
5.1 Pilot Study 
Because of the preliminary nature of this research, a pilot study was used to 
determine the best procedure for a full evaluation.  Two potential procedures differed 
in how the dependent variables of time and accuracy would be recorded. The purpose 
of the pilot study was to determine which of the two possible procedures would 
provide the best opportunity to measure differences between TreatmentExplorer and 
the text-only decision aid.  Feedback from pilot study participants was also used for 




Pilot Study Participants 
A total of n=8 participants were recruited from a convenient pool of graduate students 
and staff from the Human Computer Interaction Lab at the University of Maryland 
but none had prior experience with TreatmentExplorer as either developers or 
advisors. 
Pilot Study Materials 
Three interfaces were used during the pilot study.  The first interface was a text-based 
web-page with the information needed to answer the questionnaire questions written 
in paragraph form with both percentages and frequencies for data points.  The second 
interface was a static version of TreatmentExplorer which showed the textual 
highlights of each treatment and the final visualization.  This static version had no 
narration, animation, or text-tips.  The third interface was the fully featured version of 
TreatmentExplorer complete with narration, animation, progressive disclosure of 
highlights, and text-tips in the visualization.  A questionnaire with 10 questions about 
the risk of developing a condition and the side effects of three treatment options was 
used to elicit knowledge gains from participants.   
Pilot Study Procedures 
Each interface was pilot tested with two participants with one participant following 
the rules of Pilot Procedure 1 and the second following the rules of Pilot Procedure 2.  
Under both procedures the use of calculators, other materials, other decision aids, and 




validity of the study as patients researching treatments would likely take notes 
throughout the process.  However, the intention of the pilot and following evaluations 
was to measure how well the TreatmentExplorer prototype supported patients with 
both knowledge and recall as a stand-alone system.  Allowing participants to take 
notes would allow them to organize information for themselves and thus render any 
conclusions about the utility of the TreatmentExplorer prototype less meaningful.  
Participants were restricted to the use of their assigned decision aid and the 
questionnaire.   
Pilot Procedure 1 
The following partial procedure represents the unique steps of the first potential 
procedure: 
1. Participants read a description of the scenario and their task.  They were given 
an opportunity to ask questions. 
2. Participants were taken to the site for their decision aid. 
3. Participants were given the questionnaire and timing of their session began. 
4. Participants used their decision aid to complete their questionnaire. 
5. Participants returned their questionnaire to the researcher when finished or at 
the end of a 5 minute maximum. 
In this first procedure, participants were free to interact with their decision aid while 
they filled out the questionnaire.  Dependent variables were the total number of 
incorrect responses provided by participants and time.  Time was recorded as a 




questionnaire and stopped when the questionnaire was complete.  Participants would 
not have the opportunity to correct incorrect responses during the session.   
Two participants were recruited and followed this procedure with a higher 
time limit of 10 minutes maximum.  Both participants completed the questionnaire in 
less than 5 minutes and so the maximum time was lowered to 5 minutes for the rest of 
the pilot study. 
Pilot Procedure 2 
The following partial procedure represents the unique steps of the second potential 
procedure: 
1. Participants read a description of the scenario and their task.  They were given 
the opportunity to ask questions. 
2. Participants were taken to the site for their decision aid and given 3 minutes to 
learn the interface and investigate their treatment options (no training was 
provided at all).  They were told that they would be answering questions about 
the information in the decision aid after the three minutes were over. 
3. The browser with the decision aid site was minimized and participants were 
given their questionnaire and a maximum of one minute to answer as many 
questions as they could form the questionnaire. 
4. Researchers marked all incorrect responses and the participants were given 
more time to explore their treatment options and correct their answers until 
they were completely correct. 
In this second procedure, participant interaction with their decision aid was limited to 




was recorded.  Time would thus be recorded as the number of times participants 
needed to return to their decision aid.  This count reflects the number of consultations 
the decision aid requires before patients using it become fully knowledgeable about 
its content.  The cumulative total number of incorrect responses provided by 
participants was counted. 
 Two participants were recruited and followed this procedure with longer time 
limits for both the decision aid interaction phase and questionnaire completion phase.  
These two participants used variations of the TreatmentExplorer decision aid and 
both were able to complete their questionnaires with high accuracy after a single 
interaction with the decision aid and their questionnaire in the first attempt.  The 
maximum interaction time with the decision aid was thus lowered from 5 minutes to 3 
minutes based on observation of the first two participants’ use of the decision aids.  
Both spent the first 3 minutes intently studying the three treatment options 
methodically and the remaining 2 minutes rapidly clicking between them.  With the 
shortened time of 3 minutes, participants had enough time to watch each complete 
animation one or two times.  The questionnaire phase originally had a maximum time 
limit of two minutes.  Observation of participants completing the questionnaire in the 
questionnaire phase suggested that participants spent the first minute answering 
questions that they were certain of and making guesses for the remaining minute.  
The questionnaire phase was thus shorted to a one minute maximum for the rest of 




Pilot Participant Feedback 
As part of the pilot study procedure, all participants were given a debriefing at the end 
of their session and asked two questions: 
1. How well did this decision aid support your answering the questions on the 
questionnaire? (With 1 meaning not at all and 10 meaning very well) 
2. What feature of the decision aid did you find most useful? 
Because of the preliminary nature of this evaluation, the two subjective questions 
asked during debriefing were intended to elicit new design considerations from our 
participants.  Specifically, it was important to find out if participants made use of both 
the textual highlights and graphic visualization components of TreatmentExplorer 
equally, or whether they used the textual highlights without consulting the 
visualization. 
 The feedback from the pilot study participants was very encouraging.  Many 
remarked that the visualization component of TreatmentExplorer was the fastest way 
to answer questions and that the textual highlights served as a back-up to confirm 
what participants read from the visualization.  Participants using the fully featured, 
animated version of TreatmentExplorer remarked that the animation helped them 
remember the treatment differences and answer the questions of the questionnaire 
faster.  Participants using the animated version of TreatmentExplorer also rated their 
decision aid higher on the scale of 1 to 10 than participants given a static, non-
interactive version of TreatmentExplorer that had no accompanying narration or 
animation (8/8.5 vs. 7/6).  Further, one participant using the static version of 




between answering questions but remember them when glancing at the visualiation.  
Participants using both versions of TreatmentExplorer remarked that the bright colors 
of the visualization helped them remember the differences between treatments 
because “each picture was very distinct from the others.”   
During the pilot study, the benefit of animation and interactivity became clear 
from the comments of two participants.  One participant remarked how the animating 
bar representing condition onset “helped [her] figure out that there were two parts to 
the condition: who got it and when they got it.”  Another participant who had use of 
the static version of TreatmentExplorer commented that “[she] didn’t figure out that 
the dark bar meant something else too besides that those people got sick.”  She 
followed by adding that she only realized that condition onset information was in the 
visualization when a question on the questionnaire asked about it.  Participants using 
the static version of TreatmentExplorer also mentioned during debriefing that they 
would like to have had interactive features, including those available from the fully 
featured version of TreatmentExplorer.  Since participants had no prior experience 
with TreatmentExplorer, these were spontaneous design requests which lend support 
to the utility of the full- featured, animated version of TreatmentExplorer as an 
interactive tool. 
While the animation was clearly helpful to participants of the pilot study, a 
single feature was requested by each participant who used the fully animated version: 
the ability to quickly skip through the animation to the ending visualization.  Once 
participants had viewed the animations the first time, they wanted to be able to 




TreatmentExplorer prototype was revised to include a rapid transition to replace the 
guided narration as the default transition between treatments.  This rapid transition 
was only enabled after participants had completely viewed the guided narration for a 
treatment once.  The rapid transition followed the same steps as the guided narration 
but without pausing for user interaction or displaying in-visualization text tips.  
Participants could replay the complete narration at any time through use of the replay 
button. 
Pilot Study Summary 
The encouraging results of the pilot study suggest that the three variations of decision 
aids differ in important ways.  Firstly, participants seemed to remember more 
information from the fully featured version of TreatmentExplorer than from the static, 
non-interactive version.  Participants also subjectively rated the utility of the full 
featured TreatmentExplorer higher than the static version. 
5.2 Usability Study 
Following from the results of the procedure pilot study, a preliminary usability 
evaluation was conducted to evaluate the efficacy of the feature-complete 
TreatmentExplorer prototype.  The procedure of the full evaluation was drawn from 





This preliminary usability study was designed to answer the following research 
questions derived from the observations made during the pilot study: 
1. Are there statistically significant differences in the number of times 
participants must consult their given decision aid in order to complete the 
questionnaire? 
2. Are there statistically significant differences in the number of incorrect 
responses to questions participants provide between the three different 
decision aids? 
3. Are there statistically significant differences in the subjective ratings of 
usefulness between the three different interfaces? 
Participants 
24 participants were recruited through emails to mailing lists, paper fliers, and verbal 
advertisements.  These participants came from the undergraduate and graduate 
population at the University of Maryland and were compensated $10 for their 
participation in a session.  The procedure was refined by the results of the eight 
participant pilot study and was based on pilot procedure 2. 
Design 
This study followed a 1x3 between subjects design with participants using one of 
three possible decision aids to complete a short questionnaire about a fictitious 




build three dissimilar but equally complex sets of conditions/treatments and to lessen 
the intensity of study sessions on participants (who would have to learn detailed 
statistical information about three different conditions).   
Materials 
The three decision aids were each presented in the form of a website displayed in a 
maximized Firefox web browser on a 36x18 inch monitor set to a resolution of 1920 
x 1080 p.  Participants could use a mouse to scroll through the decision aid and point 
and click as desired. 
Decision Aid 1: Text-Only 
A text-only decision aid was created based on the layout and contents of a 2-page 
summary of Type 2 Diabetes oral medications produced by Consumer Reports 
Health: Best Buy Drugs [62] .  This decision aid was thus a realistic analog of other 
text-based decision aids that patients would likely consult when trying to choose 
between multiple treatment options available for a single condition.  (See figure 37 in 
Appendix B). 
Decision Aid 2: Static Graphic TreatmentExplorer 
A functionally limited version of TreatmentExplorer was used as a second level 
designed to provide a limited experience with TreatmentExplorer.  This version used 
the same layout and visualization as the full-featured TreatmentExplorer, however the 
guided narration, animation, progressive disclosure, and reinforcing captions were 
removed.  This eliminated all interactive features of TreatmentExplorer so that 




treatment option.  This level of interface was intended to isolate the effects of 
interaction and animation on the usability of TreatmentExplorer.  (See figure 38 in 
Appendix B). 
Decision Aid 3: Full-Featured TreatmentExplorer 
The final level of this study made use of the fully-featured TreatmentExplorer 
prototype including guided narration, animation, progressive disclosure, and 
reinforcing captions.  (See figure 39 in Appendix B). 
Data 
 A synthetic dataset was created for a fictitious condition so that no participant would 
have prior experience or knowledge of the condition, its treatments, or their side 
effects.  Participants would thus need to use the decision aids provided to them in the 
study to complete the questionnaire given to them as part of the study.  This synthetic 
data and fictitious condition also eliminated the possibility of participants ever 
developing the condition themselves in the future and drawing on information and 
experiences from this study as part of their actual personal health decision process.  
The synthetic dataset provided fictitious patient records for 120 patients dealing with 
a single medical condition and three possible treatments, each with a single unique 
adverse side effect. 
Scenario 
As part of the instructions for this study, participants read a description of their task in 
the form of the following scenario: 
“Imagine that you have recently been to your doctor’s office because you have 




tingling sensation in your fingers and toes.  Your doctor examined you and 
determined that you have developed a condition known as “Crimson Blot 
Syndrome”.  Along with uncomfortable dry skin, this condition carries a 
serious risk of sudden paralysis and needs to be treated immediately.  
Fortunately, there are several treatment options but each carries a risk of some 
side effect.  You must now make a decision about which treatment option is 
the best choice for you.   
 
To help you make this decision, you will be given a decision aid which 
explains the success rate of each treatment and its side effects.  Your doctor 
has also given you a short list of questions for you to answer about each 
treatment to help you learn about them.  You will need to be able to answer 
these questions from memory and without the use of the decision aid later.  
You will be able to use the decision aid for 3 minutes and then be asked to 
answer as many questions from the list as you can in one minute.  You will be 
able to return to the decision aid and repeat this process as many times as you 
need to complete the questionnaire.” 
Dependent Variables 
A short questionnaire of 10 questions was designed to be filled out by each 
participant while they used one of the three levels of decision aid (see Appendix A).  
This questionnaire was adapted from the “Questions You May Want to Ask Your 




[59].  Time was recorded as the cumulative sum of times a participant needed to 
consult their decision aid.  The cumulative sum of incorrect questionnaire responses 
provided by participants was also recorded.  After each chance to complete the 
questionnaire, researchers marked any incorrect response for participants.  
Participants were allowed to provide new answers after exploring treatment options 
with the decision aid.  These new answers were also marked if they were incorrect 
and added to the cumulative sum of incorrect responses.  Incomplete answers after a 
questionnaire answering phase were not counted as incorrect. 
Procedure 
The following procedure was used for each participant in this study: 
1. Participants arrived and signed a consent form.  They were told that they 
would receive $10 for the session and that a bonus was offered for the best 
performance in their group (fewest incorrect questionnaire answers with the 
fewest decision aid exploration phases used to break ties) 
2. Participants read a description of the scenario and their task.  They were given 
the opportunity to ask questions. 
3. Participants were taken to the site for their decision aid and given 3 minutes to 
learn the interface and investigate their treatment options.  They were told that 
they would be answering questions about the three treatment options once 
their 3 minute exploration time was over.  Participants did not have access to 




4. The decision aid was taken away and participants were given their 
questionnaire and a maximum of one minute to answer as many questions as 
they could.  Participants did not have access to their decision aids during the 
questionnaire answering period. 
5. Researchers marked and counted any incorrect responses and the participants 
were allowed to repeat the treatment exploration/questionnaire answering 
phases and correct their answers.  No partial credit was given, answers were 
either completely correct or marked incorrect. 
6. Participants were debriefed on the nature of the study and given the 
opportunity to ask any resulting questions.  Two subjective debriefing 
questions were also asked: 
1) How well did this decision aid support answering the questionnaire? 
(Using a scale of 1 to 10 with 1 being poorly and 10 being very well) 
2) What feature of this decision aid did you find the most helpful? 
Steps 3-5 were repeated until the questionnaire was completely and correctly filled 
out.  During the session, participants were not allowed to use calculators, consult any 
other materials, or take notes of their own.  They were also not allowed to switch 
decision aids.  Participants did not have access to both their decision aids and 
questionnaires at the same time.  They were given the same questionnaire with their 
previously marked answers to continue working from.  Participants were allowed to 
ask clarification questions if they felt they were needed to complete the questionnaire.   
 The debriefing phase (step 6) was used to elicit feedback from participants.  




question 3.  Design considerations were also sought for continued TreatmentExplorer 
development. 
Results 
A total of 28 participants volunteered to partake in the preliminary user evaluation.  
Three participants failed to arrive for their selected session.  A fourth participant’s 
results were invalidated when they disobeyed study instructions and left their 
assigned decision aid and began using a different version.  This left 24 participants 
with valid performances for analysis. 
Performance time across appeared to be affected by interface option, however 
the results were not significant after a one-way, independent-measures ANOVA 
(three treatment levels) due to high within-treatment variance (p > 0.05, F(2,21) = 
2.58, see table 4, figure 31). 
Table 4.  Means and Standard Deviations of Decision Aid Uses. 
 Text Only Static Graphic Full-Featured 
M 3.625 2.625 2.75 






Figure 31. Means and Standard Deviations of Decision Aid Uses  
Inaccurate responses were analyzed at several levels.  An initial one-way 
independent-measures ANOVA assessed the total number of incorrect responses  
participants provided for all 10 questions of the questionnaire but was not significant 
due to high within-treatment variance (p > 0.05, F(2,21) = 0.95, see table 5, figure 
32.) 
Table 5.  Means and Standard Deviation for Total Incorrect Responses 
 Text Only Static Graphic Full-Featured 
M 4.25 3.88 3 























Figure 32.  Means and Standard Deviations for Total Incorrect Responses 
Follow-up analysis separated the questions of the questionnaire into two 
groups based on the subject of the question.  The first five questions of the 
questionnaire focused on the prevalence and risk of scenario side effects.  A one-way 
independent-measures ANOVA revealed significant differences in the number of 
incorrect responses for the five questionnaire questions dealing with scenario side 
effects (p < 0.05, F(2,21) = 4.97, see table 6, figure 33).  A post-hoc Tukey’s HSD 
test revealed significant differences between the text only interface and the full-
featured interface with regards to incorrect responses.  Participants using the full-
featured interface were able to answer questions about side effects with significantly 






























Table 6.  Means and Standard Deviation for Incorrect Responses on Side-Effect Questions 
 Text Only Static Graphic Full-Featured 
M 3.75 3.125 1.625 
SD 1.67 1.46 0.92 
 
 
Figure 33. Means and Standard Deviation for Incorrect Responses on Side-Effect Questions 
 Per-question analysis revealed significant differences on question # 3 of the 
questionnaire which was “What is my risk of getting headaches if I chose Treatment 
C?”  This question was actually a trick question in that headaches were a side effect 
associated with a different treatment and the correct response to question 3 was 
“none” or “zero”.  A one-way independent-measures ANOVA indicates significant 
differences in participants’ ability to correctly answer this question (p < 0.05, 




























participants using the text-only interface answered question 3 incorrectly more times 
than participants using the other interfaces. 
Table 7. Means and Standard Deviation for Incorrect Responses on Question #3 
 Text-Only Static Graphic Full-Featured 
M 0.875 0.125 0.25 
SD 0.83 0.35 0.46 
 
 
Figure 34.  Means and Standard Deviation for Incorrect Responses on Question #3 
 The second group of five questions of the questionnaire focused on the risk of 
the primary condition of the scenario.  A one-way independent-measures ANOVA 
did not show significant differences in the incorrect responses participants provided 






























Table 8. Means and Standard Deviation for Incorrect Responses on Primary Condition 
Questions 
 Text-Only Static Graphic Full-Featured 
M 0.75 1.5 1.625 
SD 0.71 1.31 1.06 
 
 
Figure 35.  Means and Standard Deviation for Incorrect Responses on Primary Condition 
Questions 
 Finally, participants were asked for a subjective rating of the interface they 
used during the debriefing portion of their session.  A one-way independent-measures 
ANOVA did not show significant differences in the subjective rating of the interfaces 





























Table 9. Means and Standard Deviation for Participants' Subjective Interface Rating 
 Text-Only Static Graphic Full-Featured 
M 6.75 7 6.25 
SD 0.89 1.93 2.31 
 
 
Figure 36.  Means and Standard Deviations for Participants' Subjective Interface Rating 
Discussion 
While the small number of participants in this preliminary evaluation produced a high 
within-treatment variance, the results from the preliminary user evaluation suggest 
that refinements to the study procedure may produce significant results.  Overall, 
participants using the full- featured interface appeared to view their decision aid fewer 























Because the null hypothesis cannot be rejected for research question 1, it can 
be said that the guided narration and novel visualization of the fully-featured 
TreatmentExplorer did not negatively impact participant completion times.  That is, 
walking through a series of guided narration did not hinder participants when 
compared with participants using familiar formats like text.  Most participants using 
the full-featured interface needed only two interactions with the decision aid to 
complete the questionnaire (average 2.75).  Two participants in the group, however 
needed more interactions than the others and thus had a skewing effect on the group.  
Without these two scores the full- featured interface’s average time to completion 
drops to 2.3.  Similarly, most patients in the static graphic interface were also able to 
complete the questionnaire with two interactions with the interface (average 2.625).  
One participant, however, misunderstood how the timing of the study would be 
recorded and would only interact with the interface for about one minute at each 
opportunity before stating that they were done and ready for the questionnaire (other 
participants used the full 3-minute allotment).  After removing this participant’s 
relatively high number of trials, the average time to completion of the static graphic 
group drops to 2.28.   
For this preliminary evaluation, the scoring of time was kept at a high level 
and decision to count only the number of times a decision aid was consulted was 
made to encourage participants to focus on exploring the content of each decision aid, 
rather than attempting to read as fast as possible or find ways to “fast forward” 
through animations.  During the study however, it was noted that most participants 




minute of the allotted 3, explored the treatments for the next minute, and then spent 
any remaining time rapidly clicking between treatments. It also appeared that 
participants using the text-only interface did not take the time to thoroughly read the 
content of the interface.  Rather, text-only participants appeared to switch rapidly 
between treatment options and compare treatment data points individually. 
Improvements to the guided narration intended to reduce the amount of time it takes 
to view the narration have been made since the running of the evaluation.  In addition, 
other interface improvements may make the full- featured interface more memorable 
to participants with just the guided narration alone.  A future repetition of this study 
could lower the allotted time per interface interaction from the 3 minutes.  With less 
time to re-read interface content, significant differences may appear revealing which 
interface is more memorable with the least amount of interaction. 
The significant differences in participants’ ability to understand and remember 
treatment side effects is in contrast with the lack of overall significant difference in 
accuracy between interfaces.  This supports in-study observations that participants 
using the full- featured interface attempted to answer more questions each time they 
worked on their questionnaire than participants using the text-only interface.  In the 
preliminary version of this evaluation, time to completion was a separate variable 
recorded at a high level independent of each question.  Further, the number of 
unanswered questions was not tracked.  Future iterations of this evaluation should 
track both the number of unanswered questions after each attempt at the questionnaire 





Finally, because this preliminary evaluation was a between-subjects design, the 
phrasing of the question to elicit a subjective interface rating from participants likely 
needs to be changed.  The procedure of this study dictated that participants return to 
the interface and continue working on the questionnaire to correct completion.  
However, the debriefing question was phrased “On a scale of 1 to 10, how well did 
this decision aid support you in answering the questionnaire?”  Arguably, because all 
participants were able to complete the questionnaire, all participants could provide a 
high subjective rating.  Participants were also not exposed to other interface options 
which could bias them towards a more (or less) favorable rating of their interface due 
to a lack of available options.  In a future version of the study, alternate subjective 
questions could be asked such as “How easy was it to answer questions with this 
aid?” or “How easy was it to find the answers for these questions?”  Additional 
subjective questions could target specific features of each decision aid.  Because the 
null hypothesis cannot be rejected for research question 3, it can be said that the 
novelty of the full- featured interface did not adversely affect participants’ subjective 
experience and in fact the full featured and static experiences provided the subjective 
experience as familiar formats such as text. 
This preliminary evaluation attempted to simulate a realistic scenario where a 
recently-diagnosed patient must learn about several treatment options in a short 
amount of time.  However, to protect participants from the remote possibility of 
thinking they were actually being given a real diagnosis a fictitious disease was 
invented for use with the evaluation.  This fictitious disease also prevented any 




without its detractions though.  It’s possible that the obvious fiction caused 
participants to take the questionnaire less seriously thus affecting their performance in 
some way.  It is also possible that the contrived nature of the fictitious disease 
prevented participants from understanding what information they were presented 
with.  For example, the most common incorrect response across all participants in all 
groups regardless of which interface was used was mistaking the primary symptom of 
the fictitious disease for a side effect of one of its treatments.  Many participants 
listed the primary symptom as a side effect in question 1 or claimed that it was the 
most common side effect in question 2.  The use of a more realistic health condition 
might reduce the number of symptom vs. side effect errors. 
While the preliminary evaluation did not show significance for all the posited 
research questions, the results are encouraging enough to warrant further 
investigation.  Particularly, refinements to the procedure may produce greater 
differences between treatment conditions. 
5.3 Evaluation Limitations 
Participants for the pilot studies and preliminary user evaluation were both recruited 
from convenient populations of University of Maryland students, faculty, and staff 
which is somewhat limiting to the generalizability of results.  However, medical risks 
and treatment decisions are universal experiences regardless of population.  As such, 
all participants were equally qualified to provide perspective on the 
TreatmentExplorer prototype.  A greater diversity of participants in future evaluations 




evaluations should draw from diverse populations of varying age groups, computer 
skills, and literacy and education levels. 
5.4 Improvements Resulting from the Preliminary User Evaluation 
The feedback from the participants formed consensus on several points of 
improvement which have been implemented and included in the latest version of 
TreatmentExplorer. 
Separating Symptoms from Side Effects in the Legend 
The high number of symptom vs. side effect errors in the full- featured and static 
graphic conditions were unexpected and participant feedback prompted the addition 
of labels in the legend of TreatmentExplorer.  The legend was regrouped such that 
symptoms would be separate from side effects and both groups labeled. 
In-Visualization Labeling 
Many participants in the static graphic and full- featured interface groups remarked 
that while the visualization helped make the treatment differences memorable and 
made them easier to recall when working on the questionnaire, they relied on the 
treatment highlight list to inform them of the exact numeric risks associated with each 
treatment.  Others remarked that looking between a separate legend and the 
visualization took effort.  To address both these comments, additional labeling was 
added to the TreatmentExplorer visualization which provided the name of each 
colored region within that region of the visualization as well as the proportion of 




5.5 Preliminary Evaluations Summary 
Based on the feedback of domain experts, a preliminary evaluation was designed to 
begin assessing the efficacy of the TreatmentExplorer prototype.  A small pilot study 
was used to determine the best procedure and the parameters for a larger evaluation.  
Feedback from the pilot study resulted in minor modifications to the treatment 
transition animations to better support comparison between treatments.  Results from 
the preliminary evaluation were promising and indicated that participants assisted by 
the full-featured TreatmentExplorer prototype were better able to understand both 
primary conditions and treatment side effects better than participants using other 
versions of the prototype.  Additional feedback from the full evaluation has resulted 
in interface improvements to the full featured TreatmentExplorer prototype.  
Particularly, the organization of the legend has been improved to distinguish 
condition symptoms from treatment side effects and additional labels have been 
included to improve the readability of the visualization.  Improvements to the 
evaluation procedure have been made and a follow-up evaluation is planned to study 





Chapter 6:  Conclusions and Future Work 
 
 
6.1 Medical Risk Communication and Treatment Exploration Using 
TreatmentExplorer 
TreatmentExplorer is a prototype decision aid designed to allow patients to explore 
their treatment options and educate themselves on the associated risks of their 
condition and its treatments.  It is capable of showing the likely outcomes of 
treatment options based on the actual outcomes of similar patients and includes 
information that would otherwise be scattered amongst disparate decision aids.  
Though graphics, animation, and guided narration patients with no prior experience 
can quickly learn both the system and the treatment information it contains.  Data 
personalized to the patient increases the relevancy of TreatmentExplorer’s 
presentation.  It can provide a starting point for patients to discuss treatment outcomes 
with their physicians and other medical professionals on their care team.  Patients 
with greater understanding of their conditions will be more prepared to take greater 
responsibility for their care and to assert their preferences.  Preliminary evaluations 
show promising results which suggest that TreatmentExplorer is an effective tool for 




6.2 Guidelines for Interactive Medical Decision Aids 
TreatmentExplorer has been evaluated with a number of experts as well as pilot tested 
with a small group of users and finally compared against other versions of a similar 
interface through a preliminary evaluation.  The feedback and performance of these 
users has provided insight into best-practices or the design of interactive decision aids 
for medical risk communication and treatment exploration.  The following guidelines 
have been distilled from the TreatmentExplorer design process and evaluation.   
Use of Text 
Use Text to Support Graphics 
Text is useful for concisely communicating a specific data point.  However, text is 
frequently not memorable and many patients will prefer to use a short bulleted list 
rather than read large paragraphs of text.  Text should therefore be used to support the 
meaning of graphics and not be the only representation of a data point in a decision 
aid.  
Use Simple Sentence Structure 
Patients seeking information from a decision aid may be pressed for time or facing 
other stressors at the time.  They will be interested in obtaining information as 
quickly as possible.  In addition literacy is highly variable among patients who need 
information from a decision aid. Simple sentence structures should be used so that 
information can be easily processed by patients who may be rushing or under duress. 




Use of Graphics 
Label All Graphics 
Patients using a decision aid will have varying levels of familiarity with graphics and 
numerical information.  Graphics need to be placed into a context with labels so that 
patients can quickly understand what information they can expect to learn from a 
graphic. 
Label Graph Pieces 
Varying competencies with graphics also implies that patients will need assistance to 
understand the information conveyed in a graphic.  In order to make graphics fully 
useful to patients, labels should be used to help patients understand how to interpret 
individual portions of a graphic.  Graphic axes may not be enough to help patients 
understand numeric values conveyed by a graph.  
Organize/Order Legends to Show Data Structure 
Graphic legends can be used to set up patient expectations about graphics by 
suggesting what information is portrayed in a graphic.  If the data follows an implied 
structure this structure should be reflected in the legend.  For TreatmentExplorer, this 
means that symptoms of a condition and side effects of treatments should be 
separated from each other and labeled.  There is value in communicating graphic 




Use of Animation 
Provide User Control for Animation Speed 
Patients will have varying degrees of comfort with computer use and animated 
graphics.  Some patients will be impatient with slow moving graphics while others 
intimidated by rapidly changing visualizations.  The same patient may want to view 
the same animation at different speeds depending on how well they understand the 
meaning of the animation.  Patients should have the ability to control the speed at 
which animations occur. 
Animate One Object with One Movement per Step 
Patients consulting a decision aid are motivated to learn the information it contains.  
Using simple animations will support the message of a decision aid without being a 
distraction.  Animation should be minimal with one animation used to represent only 
one data point.  In order to allow patients to fully absorb and understand the data 
point, only one should be expressed at a time suggesting simplistic animations with 
only one object in motion at a time are best. 
Use of Guided Narration 
Begin Each Narration from the Same State 
Patients are perceptive of subtle unintended differences and will question the meaning 
of inconsistencies when they appear.  To avoid this accidental confusion, all 
narrations should begin from the same clear starting state.  This will help patients 
learn to separate narratives and understand that the data presented in one narration is 




Follow a Consistent Narration Order 
Patients who watch a series of narrations will learn the order of information and begin 
to expect data points to follow the prescribed sequence.  This not only helps them to 
structure how they think about the data but also provides a way to help patients 
compare data points across narration.  Patients who are learning a narrative interface 
will also be less intimidated if their expectations about what will happen next are not 
defied.  Thus, following a consistent order with all treatment narratives will make the 
narration more accessible. 
Provide Both Replay and Skip-Through Options 
Some patients will find value in re-watching a narration if they feel they missed some 
information in prior viewings.  Other patients will be quick to absorb information 
from a narration and feel they only need to see it once.  These patients may only need 
a quick reminder of the final state of a narration later.  Providing options for patients 
to quickly skip to the end of a narration will allow them to refresh their memory while 
full replay options will support patients who feel they have missed information or 
want to view the detailed explanation again. 
Explain One Data Point per Stage 
Following from the recommendations to use simple sentence structures and simple 
animations, stages of narration should also be simple to allow patients to focus their 
attention on one data point at a time.  Related data points should be grouped into a 




Give Users Control of the Flow of Narration 
Patients interacting with a guided narration will be trying to understand the 
information presented to them and learn from the narration.  Some patients may need 
to re-read text or re-think accompanying animation several times to feel comfortable.  
Patients should then have the control to decide when the narration advances to the 
next stage.  This may mean providing patients with options to control the speed of an 
auto-playing narration or pausing and waiting for patients to indicate that they are 
ready for the next step before the narration advances. 
6.3 Limitations 
Dataset Limitations 
TreatmentExplorer is envisioned to operate as part of a clinical records system where 
it would have access to large numbers of electronic health records.  These patient 
records would serve as the data source.  TreatmentExplorer would aggregate data 
from patients similar to a given patient in order to provide relevant treatment 
outcomes.  As a prototype, however, it has been built using synthetic data and not 
tested on actual patient records.  This limits the prototype’s initial readiness to handle 
actual patient records.  While the data of the preliminary user evaluation was truly 
fictitious, other data sets have been created based on real-world statistics available 
from credible organizations.  These realistic datasets have been used to guide the 
development of TreatmentExplorer so that it will be better prepared for the 




TreatmentExplorer to include capabilities to draw data from more realistic sources 
such as anonymized patient records. 
Problem Scope Limitations 
Medical risk communication is a vast field with many research questions left to be 
answered.  Continued research is needed to identify the best practices for designing 
decision aids.  TreatmentExplorer is a limited exploration into the efficacy of 
applying information visualization strategies such as animation, interaction, and 
guided narration to these diverse fields of research.  With its design and early 
evaluations, TreatmentExplorer has been demonstrated to be a viable tool for 
continued exploration.  Future work will continue to explore subtleties of animation, 
graphics and text use, and interaction. 
6.4 Future Work 
The TreatmentExplorer prototype has been established as a first step towards meeting 
the design goals established in Chapter 1 and supporting patients in making better 
healthcare decisions.  Because of its early stage of development, there are several 
directions future work could take. 
Technical Improvements 
Several simplifying assumptions were made to speed the development of 
TreatmentExplorer.  Firstly, it was assumed that patients would be investigating 




alleviated.  Secondly, treatments were assumed to have one adverse side effect.  
Thirdly, the prototype was visually laid out to accommodate a small number of 
treatment options (though a maximum number of treatment options is not set or 
enforced anywhere in the code base).  Each of these assumptions must be addressed 
by future work in order to improve the scalability of the prototype.  Additionally, 
future work should attempt to make use of real clinical data instead of the synthetic 
datasets used during this phase of development.  Future research related to the 
development of TreatmentExplorer is also needed to understand how to best reconcile 
large, broadly distributed EHR data sources with locally provided EHRs.  Small 
clinics may need to draw from nationally established records systems but it is 
possibly that patients would be best served if records were weighted to lend more 
importance to the outcomes of local patients when possible.  
Additional Features 
A minimal set of desired features has been implemented in this prototype.  Feedback 
from expert reviewers and study participants have provided a number of additional 
desired features ranging from the inclusion of more measurements (treatment costs, 
subjective ratings from other patients, ranking treatments by invasiveness, etc.) to 
additions to the guided narration.  A frequently discussed idea is that of spoken 
narration.  Combining text and graphics necessarily splits a patient’s attention 
between reading text and visual processing of graphics.  Spoken narration might be a 




current implementation as an HTML based web site this will require extensive 
technical work). 
User Experience Improvements 
The preliminary work on TreatmentExplorer often sacrificed aesthetics for 
functionality.  Several participants commented on the color choices in particular.  
While some felt the bold colors made the visualization very memorable, others 
remarked that they were too striking.  The current color selections were chosen to 
support fully colorblind patients by default at the request of one of the expert 
reviewers.  Future work should improve the balance between inviting, user-pleasing 
aesthetics and function. 
Evaluations 
The preliminary evaluations conducted as part of this thesis focused on determining 
whether or not the TreatmentExplorer prototype showed any indication of 
improvement over a baseline comparative decision aid.  A text-only baseline was 
chosen to reduce development time needed before evaluations could take place.  
Other, more complex baselines should be used in future evaluations to address the 
utility of the TreatmentExplroer visualization specifically.  It is possible that a set of 
coordinated and interactive basic graphs such as bar and line charts could produce 
similar knowledge gains as TreatmentExplorer.  Future evaluations should also seek 
to better measure how quickly participants are able to learn about treatments as well 




time days or weeks after using TreatmentExplorer).  Future evaluations must also 
seek to test the efficacy of TreatmentExplorer with more representative users.  Other 
populations such as the elderly and patients currently undergoing treatment decisions 
should be consulted for design feedback as well as recruited for additional controlled 
studies. 
Additional Use Scenarios 
This thesis work has focused on addressing the needs of patients making a single 
healthcare decision.  But the TreatmentExplorer prototype could be studied in other 
contexts in the future.  One possibility is to improve informed consent processes in 
medical research.  Potential participants could use TreatmentExplorer to obtain a 
more complete picture of what they can anticipate experimental procedures to entail.  
This would be an improvement over current practices which provide minimal 
information, typically in text format.  Another possible use scenario is that of policy 
decision making.  This would involve a different interpretation of “treatment” and 
represent different populations as they are affected by potential policy changes.  
Policy makers could use TreatmentExplorer to understand different variations of the 
same policy on one population or to understand how different populations fare under 
a single policy. 
Conclusion 




1) A multi-dimensional model for describing the content of decision aids based 
on an extensive literature review 
2) A prototype interactive decision aid, TreatmentExplorer, designed to 
communicate treatment risks and benefits through a guided narration and 
animation 
3) An evaluation of TreatmentExplorer with four experts in health 
communication 
4) A preliminary usability evaluation comparing the performance of 
TreatmentExplorer against design alternatives 
5) Guidelines for interactive decision aids based on the results of these 






Appendix A: User Evaluation Materials 
User Evaluation Scenario 
Imagine that you have recently been to your doctor’s office because you have 
been experiencing dry, red skin on your hands and feet as well as a mild tingling 
sensation in your fingers and toes.  Your doctor examined you and determined that 
you have developed a condition known as “Crimson Blot Syndrome”.  Along with 
uncomfortable dry skin, this condition carries a serious risk of sudden paralysis and 
needs to be treated immediately.  Fortunately, there are several treatment options but 
each carries a risk of some side effect.  You must now make a decision about which 
treatment options is the best choice for you.   
 
To help you make this decision, you will be given a decision aid which 
explains the success rate of each treatment and its side effects.  Your doctor has also 
given you a short list of questions for you to answer about each treatment to help you 
learn about them.  You will need to be able to answer these questions from memory 
and without the use of the decision aid later.  You will be able to use the decision aid 
for 3 minutes and then be asked to answer as many questions from the list as you can 
in one minute.  You will be able to return to the decision aid and repeat this process 





User Evaluation Questionnaire 




 What is the most common side effect of treating CBS? 
 
 
 What is my risk of getting headaches if I chose Treatment C? 
 
 
 When can I expect headaches if I chose Treatment B? 
 
 
 What is my risk of severe rash if I chose Treatment A? 
 
 
 Which treatment has the highest risk of paralysis? 
 
 
 What is my risk of paralysis if I chose Treatment C? 
 
 
 When can I expect paralysis to occur if I chose Treatment A? 
 
 
 Which treatment has the earliest average onset of paralysis? 
 
 













Static Graphic Interface 
 
Figure 38.  Screen capture of the static graphic interface used in the preliminary user evaluation 






Figure 39.  Screen capture of the full-featured interface used in the preliminary evaluation.  This 





Appendix C: TreatmentExplorer Code and Demo 
 
Code 
The code for the latest prototype version of TreatmentExplorer as completed for this 
thesis project can be downloaded from: 
http://www.cs.umd.edu/~lyndsey/TreatmentExplorer.zip  
This package contains the source code and five synthetic datasets which together can 
be used to run TreatmentExplorer.  Included in the five synthetic datasets is the 
dataset used in the evaluations of TreatmentExplorer. 
Demo 
For a demonstration of this thesis project using the dataset built for the 
TreatmentExplorer user evaluations, visit  
 http://www.cs.umd.edu/hcil/treatmentexplorer/ 
To change to a different dataset from the included five synthetic datasets, edit the 
_Scenario variable located in the script section of demo.html. 
Using New Datasets for New Applications 
The code provided in the TreatmentExplorer.zip has a JavaScript file called data.js 
which is located in the js directory.  This script loads a dataset based on a global 
variable, _Scenario.  _Scenario is created and set in the script section of demo.html at 




 To use a new dataset with TreatmentExplorer: 
1. Create Two Files for Your Dataset: a meta file and a records file.  The meta 
file describes how the events in the records file are to be interpreted by 
TreatmentExplorer.  The records file contains the raw events to be 
represented. 
2. Edit data.js: data.js already has a file-loading section of script which reads 
the contents of a meta- and records-file.  You may add to the switch statement 
which selects from the five synthetic demo datasets or remove the switch 
leaving only your loading code. 
3. (Optional) Edit demo.html: demo.html is intended to demonstrate all 
versions of TreatmentExplorer and to provide an easy mechanism.  You may 
remove versions of the prototype from display by editing demo.html and 
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